{
  "cells": [
    {
      "cell_type": "code",
      "execution_count": 1,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Ez8OIfMDU-fQ",
        "outputId": "f3a27e1c-f93f-4330-dd4a-3e2ace6c9a01"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Mounted at /content/drive\n"
          ]
        }
      ],
      "source": [
        "from google.colab import drive\n",
        "drive.mount('/content/drive')"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "!pip install pdfplumber\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "_QVPtcIQlcih",
        "outputId": "6dfccadf-4610-4719-d8f2-f1b5fce658eb"
      },
      "execution_count": 5,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Collecting pdfplumber\n",
            "  Downloading pdfplumber-0.11.4-py3-none-any.whl.metadata (41 kB)\n",
            "\u001b[?25l     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m0.0/42.0 kB\u001b[0m \u001b[31m?\u001b[0m eta \u001b[36m-:--:--\u001b[0m\r\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m42.0/42.0 kB\u001b[0m \u001b[31m1.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hCollecting pdfminer.six==20231228 (from pdfplumber)\n",
            "  Downloading pdfminer.six-20231228-py3-none-any.whl.metadata (4.2 kB)\n",
            "Requirement already satisfied: Pillow>=9.1 in /usr/local/lib/python3.10/dist-packages (from pdfplumber) (10.4.0)\n",
            "Collecting pypdfium2>=4.18.0 (from pdfplumber)\n",
            "  Downloading pypdfium2-4.30.0-py3-none-manylinux_2_17_x86_64.manylinux2014_x86_64.whl.metadata (48 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m48.5/48.5 kB\u001b[0m \u001b[31m1.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: charset-normalizer>=2.0.0 in /usr/local/lib/python3.10/dist-packages (from pdfminer.six==20231228->pdfplumber) (3.4.0)\n",
            "Requirement already satisfied: cryptography>=36.0.0 in /usr/local/lib/python3.10/dist-packages (from pdfminer.six==20231228->pdfplumber) (43.0.3)\n",
            "Requirement already satisfied: cffi>=1.12 in /usr/local/lib/python3.10/dist-packages (from cryptography>=36.0.0->pdfminer.six==20231228->pdfplumber) (1.17.1)\n",
            "Requirement already satisfied: pycparser in /usr/local/lib/python3.10/dist-packages (from cffi>=1.12->cryptography>=36.0.0->pdfminer.six==20231228->pdfplumber) (2.22)\n",
            "Downloading pdfplumber-0.11.4-py3-none-any.whl (59 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m59.2/59.2 kB\u001b[0m \u001b[31m4.0 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading pdfminer.six-20231228-py3-none-any.whl (5.6 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m5.6/5.6 MB\u001b[0m \u001b[31m50.4 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading pypdfium2-4.30.0-py3-none-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (2.8 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m2.8/2.8 MB\u001b[0m \u001b[31m73.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hInstalling collected packages: pypdfium2, pdfminer.six, pdfplumber\n",
            "Successfully installed pdfminer.six-20231228 pdfplumber-0.11.4 pypdfium2-4.30.0\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import pdfplumber\n",
        "import json\n",
        "import re\n",
        "\n",
        "# Path to your PDF file\n",
        "pdf_path = '/content/drive/MyDrive/project_ir/Depressive Disorders.pdf'\n",
        "\n",
        "# Function to parse PDF into hierarchical JSON using regex\n",
        "def parse_pdf_to_json_with_regex(pdf_path):\n",
        "    json_structure = {}\n",
        "    section_stack = [json_structure]\n",
        "\n",
        "    # Define regex patterns for different levels in the text\n",
        "    patterns = [\n",
        "        (r\"^\\d+\\s+\", 1),       # Matches sections like \"1 \"\n",
        "        (r\"^\\d+\\.\\d+\\s+\", 2),   # Matches subsections like \"1.1 \"\n",
        "        (r\"^[A-Z]\\s+\", 3),      # Matches items like \"A \", \"B \"\n",
        "        (r\"^[A-Z]\\.\\d+\\s+\", 4), # Matches sub-items like \"A.1 \", \"B.2 \"\n",
        "    ]\n",
        "\n",
        "    with pdfplumber.open(pdf_path) as pdf:\n",
        "        # Iterate through each page\n",
        "        for page in pdf.pages:\n",
        "            text = page.extract_text()\n",
        "\n",
        "            # Process each line individually\n",
        "            for line in text.splitlines():\n",
        "                line = line.strip()\n",
        "                matched = False\n",
        "\n",
        "                # Check each pattern to determine its hierarchy level\n",
        "                for pattern, level in patterns:\n",
        "                    if re.match(pattern, line):\n",
        "                        content = re.sub(pattern, \"\", line)\n",
        "                        key = f\"{level}.{len(section_stack[-1]) + 1}\"\n",
        "\n",
        "                        # Navigate to the correct depth\n",
        "                        while len(section_stack) > level:\n",
        "                            section_stack.pop()\n",
        "\n",
        "                        # Add content to JSON structure at the appropriate level\n",
        "                        section_stack[-1][key] = content\n",
        "\n",
        "                        # Push new level if needed\n",
        "                        if isinstance(section_stack[-1][key], dict):\n",
        "                            section_stack.append(section_stack[-1][key])\n",
        "\n",
        "                        matched = True\n",
        "                        break\n",
        "\n",
        "                # Handle lines that don't match any known pattern\n",
        "                if not matched:\n",
        "                    section_stack[-1][f\"{len(section_stack[-1]) + 1}\"] = line\n",
        "\n",
        "    return json_structure\n",
        "\n",
        "# Convert parsed structure to JSON\n",
        "hierarchical_json = parse_pdf_to_json_with_regex(pdf_path)\n",
        "print(json.dumps(hierarchical_json, indent=2))\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "3ABWg-VNl8yv",
        "outputId": "13a37b4d-822e-4af3-d847-8c9a39c3208e"
      },
      "execution_count": 8,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "{\n",
            "  \"1\": \"Depressive\",\n",
            "  \"2\": \"Disorders\",\n",
            "  \"3\": \"Depressive disorders\",\n",
            "  \"4\": \"include disruptive mood dysregulation disorder, major\",\n",
            "  \"5\": \"depressive disorder (including major depressive episode), persistent depressive disorder\",\n",
            "  \"6\": \"(dysthymia), premenstrual dysphoric disorder, substance/medication-induced depres-\",\n",
            "  \"7\": \"sive disorder, depressive disorder due to another medical condition, other specified de-\",\n",
            "  \"8\": \"pressive disorder, and unspecified depressive disorder. Unlike in DSM-IV, this chapter\",\n",
            "  \"9\": \"\\u201cDepressive Disorders\\u201d has been separated from the previous chapter \\u201cBipolar and Re-\",\n",
            "  \"10\": \"lated Disorders.\\u201d The common feature of all of these disorders is the presence of sad,\",\n",
            "  \"11\": \"empty, or irritable mood, accompanied by somatic and cognitive changes that signifi-\",\n",
            "  \"12\": \"cantly affect the individual\\u2019s capacity to function. What differs among them are issues of\",\n",
            "  \"13\": \"duration, timing, or presumed etiology.\",\n",
            "  \"14\": \"In order to address concerns about the potential for the overdiagnosis of and treatment\",\n",
            "  \"15\": \"for bipolar disorder in children, a new diagnosis, disruptive mood dysregulation disorder,\",\n",
            "  \"16\": \"referring to the presentation of children with persistent irritability and frequent episodes\",\n",
            "  \"17\": \"of extreme behavioral dyscontrol, is added to the depressive disorders for children up to\",\n",
            "  \"1.18\": \"years of age. Its placement in this chapter reflects the finding that children with this\",\n",
            "  \"19\": \"symptom pattern typically develop unipolar depressive disorders or anxiety disorders,\",\n",
            "  \"20\": \"rather than bipolar disorders, as they mature into adolescence and adulthood.\",\n",
            "  \"21\": \"Major depressive disorder represents the classic condition in this group of disorders. It\",\n",
            "  \"22\": \"is characterized by discrete episodes of at least 2 weeks\\u2019 duration (although most episodes\",\n",
            "  \"23\": \"last considerably longer) involving clear-cut changes in affect, cognition, and neurovege-\",\n",
            "  \"24\": \"tative functions and inter-episode remissions. A diagnosis based on a single episode is\",\n",
            "  \"25\": \"possible, although the disorder is a recurrent one in the majority of cases. Careful consid-\",\n",
            "  \"26\": \"eration is given to the delineation of normal sadness and grief from a major depressive ep-\",\n",
            "  \"27\": \"isode. Bereavement may induce great suffering, but it does not typically induce an episode\",\n",
            "  \"28\": \"of major depressive disorder. When they do occur together, the depressive symptoms and\",\n",
            "  \"29\": \"functional impairment tend to be more severe and the prognosis is worse compared with\",\n",
            "  \"30\": \"bereavement that is not accompanied by major depressive disorder. Bereavement-related\",\n",
            "  \"31\": \"depression tends to occur in persons with other vulnerabilities to depressive disorders,\",\n",
            "  \"32\": \"and recovery may be facilitated by antidepressant treatment.\",\n",
            "  \"3.33\": \"more chronic form of depression, persistent depressive disorder (dysthymia), can be\",\n",
            "  \"34\": \"diagnosed when the mood disturbance continues for at least 2 years in adults or 1 year in\",\n",
            "  \"35\": \"children. This diagnosis, new in DSM-5, includes both the DSM-IV diagnostic categories of\",\n",
            "  \"36\": \"chronic major depression and dysthymia.\",\n",
            "  \"37\": \"After careful scientific review of the evidence, premenstrual dysphoric disorder has\",\n",
            "  \"38\": \"been moved from an appendix of DSM-IV (\\u201cCriteria Sets and Axes Provided for Further\",\n",
            "  \"39\": \"Study\\u201d) to Section II of DSM-5. Almost 20 years of additional of research on this condition\",\n",
            "  \"40\": \"has confirmed a specific and treatment-responsive form of depressive disorder that begins\",\n",
            "  \"41\": \"sometime following ovulation and remits within a few days of menses and has a marked\",\n",
            "  \"42\": \"impact on functioning.\",\n",
            "  \"3.43\": \"large number of substances of abuse, some prescribed medications, and several\",\n",
            "  \"44\": \"medical conditions can be associated with depression-like phenomena. This fact is recog-\",\n",
            "  \"45\": \"nized in the diagnoses of substance/medication-induced depressive disorder and depres-\",\n",
            "  \"46\": \"sive disorder due to another medical condition.\",\n",
            "  \"47\": \"155\",\n",
            "  \"1.48\": \"Depressive Disorders\",\n",
            "  \"49\": \"Disruptive Mood Dysregulation Disorder\",\n",
            "  \"50\": \"Diagnostic Criteria 296.99 (F34.8)\",\n",
            "  \"51\": \"A. Severe recurrent temper outbursts manifested verbally (e.g., verbal rages) and/or be-\",\n",
            "  \"52\": \"haviorally (e.g., physical aggression toward people or property) that are grossly out of\",\n",
            "  \"53\": \"proportion in intensity or duration to the situation or provocation.\",\n",
            "  \"54\": \"B. The temper outbursts are inconsistent with developmental level.\",\n",
            "  \"55\": \"C. The temper outbursts occur, on average, three or more times per week.\",\n",
            "  \"56\": \"D. The mood between temper outbursts is persistently irritable or angry most of the day,\",\n",
            "  \"57\": \"nearly every day, and is observable by others (e.g., parents, teachers, peers).\",\n",
            "  \"58\": \"E. Criteria A\\u2013D have been present for 12 or more months. Throughout that time, the indi-\",\n",
            "  \"59\": \"vidual has not had a period lasting 3 or more consecutive months without all of the\",\n",
            "  \"60\": \"symptoms in Criteria A\\u2013D.\",\n",
            "  \"61\": \"F. Criteria A and D are present in at least two of three settings (i.e., at home, at school,\",\n",
            "  \"62\": \"with peers) and are severe in at least one of these.\",\n",
            "  \"63\": \"G. The diagnosis should not be made for the first time before age 6 years or after age 18\",\n",
            "  \"64\": \"years.\",\n",
            "  \"65\": \"H. By history or observation, the age at onset of Criteria A\\u2013E is before 10 years.\",\n",
            "  \"66\": \"I. There has never been a distinct period lasting more than 1 day during which the full\",\n",
            "  \"67\": \"symptom criteria, except duration, for a manic or hypomanic episode have been met.\",\n",
            "  \"68\": \"Note: Developmentally appropriate mood elevation, such as occurs in the context of a\",\n",
            "  \"69\": \"highly positive event or its anticipation, should not be considered as a symptom of ma-\",\n",
            "  \"70\": \"nia or hypomania.\",\n",
            "  \"71\": \"J. The behaviors do not occur exclusively during an episode of major depressive disorder\",\n",
            "  \"72\": \"and are not better explained by another mental disorder (e.g., autism spectrum disor-\",\n",
            "  \"73\": \"der, posttraumatic stress disorder, separation anxiety disorder, persistent depressive\",\n",
            "  \"74\": \"disorder [dysthymia]).\",\n",
            "  \"75\": \"Note: This diagnosis cannot coexist with oppositional defiant disorder, intermittent ex-\",\n",
            "  \"76\": \"plosive disorder, or bipolar disorder, though it can coexist with others, including major\",\n",
            "  \"77\": \"depressive disorder, attention-deficit/hyperactivity disorder, conduct disorder, and\",\n",
            "  \"78\": \"substance use disorders. Individuals whose symptoms meet criteria for both disruptive\",\n",
            "  \"79\": \"mood dysregulation disorder and oppositional defiant disorder should only be given the\",\n",
            "  \"80\": \"diagnosis of disruptive mood dysregulation disorder. If an individual has ever experi-\",\n",
            "  \"81\": \"enced a manic or hypomanic episode, the diagnosis of disruptive mood dysregulation\",\n",
            "  \"82\": \"disorder should not be assigned.\",\n",
            "  \"83\": \"K. The symptoms are not attributable to the physiological effects of a substance or to an-\",\n",
            "  \"84\": \"other medical or neurological condition.\",\n",
            "  \"85\": \"Diagnostic Features\",\n",
            "  \"86\": \"The core feature of disruptive mood dysregulation disorder is chronic, severe persistent ir-\",\n",
            "  \"87\": \"ritability. This severe irritability has two prominent clinical manifestations, the first of\",\n",
            "  \"88\": \"which is frequent temper outbursts. These outbursts typically occur in response to frus-\",\n",
            "  \"89\": \"tration and can be verbal or behavioral (the latter in the form of aggression against prop-\",\n",
            "  \"90\": \"erty, self, or others). They must occur frequently (i.e., on average, three or more times per\",\n",
            "  \"91\": \"week) (Criterion C) over at least 1 year in at least two settings (Criteria E and F), such as in\",\n",
            "  \"92\": \"the home and at school, and they must be developmentally inappropriate (Criterion B).\",\n",
            "  \"93\": \"The second manifestation of severe irritability consists of chronic, persistently irritable or\",\n",
            "  \"94\": \"angry mood that is present between the severe temper outbursts. This irritable or angry\",\n",
            "  \"95\": \"mood must be characteristic of the child, being present most of the day, nearly every day,\",\n",
            "  \"96\": \"and noticeable by others in the child\\u2019s environment (Criterion D).\",\n",
            "  \"97\": \"Disruptive Mood Dysregulation Disorder 157\",\n",
            "  \"98\": \"The clinical presentation of disruptive mood dysregulation disorder must be carefully\",\n",
            "  \"99\": \"distinguished from presentations of other, related conditions, particularly pediatric bi-\",\n",
            "  \"100\": \"polar disorder. In fact, disruptive mood dysregulation disorder was added to DSM-5 to\",\n",
            "  \"101\": \"address the considerable concern about the appropriate classification and treatment of\",\n",
            "  \"102\": \"children who present with chronic, persistent irritability relative to children who present\",\n",
            "  \"103\": \"with classic (i.e., episodic) bipolar disorder.\",\n",
            "  \"104\": \"Some researchers view severe, non-episodic irritability as characteristic of bipolar dis-\",\n",
            "  \"105\": \"order in children, although both DSM-IV and DSM-5 require that both children and adults\",\n",
            "  \"106\": \"have distinct episodes of mania or hypomania to qualify for the diagnosis of bipolar I dis-\",\n",
            "  \"107\": \"order. During the latter decades of the 20th century, this contention by researchers that\",\n",
            "  \"108\": \"severe, nonepisodic irritability is a manifestation of pediatric mania coincided with an up-\",\n",
            "  \"109\": \"surge in the rates at which clinicians assigned the diagnosis of bipolar disorder to their\",\n",
            "  \"110\": \"pediatric patients. This sharp increase in rates appears to be attributable to clinicians com-\",\n",
            "  \"111\": \"bining at least two clinical presentations into a single category. That is, both classic, epi-\",\n",
            "  \"112\": \"sodic presentations of mania and non-episodic presentations of severe irritability have\",\n",
            "  \"113\": \"been labeled as bipolar disorder in children. In DSM-5, the term bipolar disorder is explicitly\",\n",
            "  \"114\": \"reserved for episodic presentations of bipolar symptoms. DSM-IV did not include a diagno-\",\n",
            "  \"115\": \"sis designed to capture youths whose hallmark symptoms consisted of very severe, non-\",\n",
            "  \"116\": \"episodic irritability, whereas DSM-5, with the inclusion of disruptive mood dysregulation\",\n",
            "  \"117\": \"disorder, provides a distinct category for such presentations.\",\n",
            "  \"118\": \"Prevalence\",\n",
            "  \"119\": \"Disruptive mood dysregulation disorder is common among children presenting to pedi-\",\n",
            "  \"120\": \"atric mental health clinics. Prevalence estimates of the disorder in the community are un-\",\n",
            "  \"121\": \"clear. Based on rates of chronic and severe persistent irritability, which is the core feature\",\n",
            "  \"122\": \"of the disorder, the overall 6-month to 1-year period-prevalence of disruptive mood dys-\",\n",
            "  \"123\": \"regulation disorder among children and adolescents probably falls in the 2%\\u20135% range.\",\n",
            "  \"124\": \"However, rates are expected to be higher in males and school-age children than in females\",\n",
            "  \"125\": \"and adolescents.\",\n",
            "  \"126\": \"Development and Course\",\n",
            "  \"127\": \"The onset of disruptive mood dysregulation disorder must be before age 10 years, and the\",\n",
            "  \"128\": \"diagnosis should not be applied to children with a developmental age of less than 6 years.\",\n",
            "  \"129\": \"It is unknown whether the condition presents only in this age-delimited fashion. Because\",\n",
            "  \"130\": \"the symptoms of disruptive mood dysregulation disorder are likely to change as children\",\n",
            "  \"131\": \"mature, use of the diagnosis should be restricted to age groups similar to those in which\",\n",
            "  \"132\": \"validity has been established (7\\u201318 years). Approximately half of children with severe,\",\n",
            "  \"133\": \"chronic irritability will have a presentation that continues to meet criteria for the condition\",\n",
            "  \"1.134\": \"year later. Rates of conversion from severe, nonepisodic irritability to bipolar disorder\",\n",
            "  \"135\": \"are very low. Instead, children with chronic irritability are at risk to develop unipolar de-\",\n",
            "  \"136\": \"pressive and/or anxiety disorders in adulthood.\",\n",
            "  \"137\": \"Age-related variations also differentiate classic bipolar disorder and disruptive mood\",\n",
            "  \"138\": \"dysregulation disorder. Rates of bipolar disorder generally are very low prior to adoles-\",\n",
            "  \"139\": \"cence (<1%), with a steady increase into early adulthood (1%\\u20132% prevalence). Disruptive\",\n",
            "  \"140\": \"mood dysregulation disorder is more common than bipolar disorder prior to adolescence,\",\n",
            "  \"141\": \"and symptoms of the condition generally become less common as children transition into\",\n",
            "  \"142\": \"adulthood.\",\n",
            "  \"143\": \"Risk and Prognostic Factors\",\n",
            "  \"144\": \"Temperamental. Children with chronic irritability typically exhibit complicated psy-\",\n",
            "  \"145\": \"chiatric histories. In such children, a relatively extensive history of chronic irritability is\",\n",
            "  \"1.146\": \"Depressive Disorders\",\n",
            "  \"147\": \"common, typically manifesting before full criteria for the syndrome are met. Such predi-\",\n",
            "  \"148\": \"agnostic presentations may have qualified for a diagnosis of oppositional defiant disorder.\",\n",
            "  \"149\": \"Many children with disruptive mood dysregulation disorder have symptoms that also\",\n",
            "  \"150\": \"meet criteria for attention-deficit/hyperactivity disorder (ADHD) and for an anxiety dis-\",\n",
            "  \"151\": \"order, with such diagnoses often being present from a relatively early age. For some chil-\",\n",
            "  \"152\": \"dren, the criteria for major depressive disorder may also be met.\",\n",
            "  \"153\": \"Genetic and physiological. In terms of familial aggregation and genetics, it has been\",\n",
            "  \"154\": \"suggested that children presenting with chronic, non-episodic irritability can be differen-\",\n",
            "  \"155\": \"tiated from children with bipolar disorder in their family-based risk. However, these two\",\n",
            "  \"156\": \"groups do not differ in familial rates of anxiety disorders, unipolar depressive disorders,\",\n",
            "  \"157\": \"or substance abuse. Compared with children with pediatric bipolar disorder or other men-\",\n",
            "  \"158\": \"tal illnesses, those with disruptive mood dysregulation disorder exhibit both commonal-\",\n",
            "  \"159\": \"ities and differences in information-processing deficits. For example, face-emotion\",\n",
            "  \"160\": \"labeling deficits, as well as perturbed decision making and cognitive control, are present in\",\n",
            "  \"161\": \"children with bipolar disorder and chronically irritable children, as well as in children\",\n",
            "  \"162\": \"with some other psychiatric conditions. There is also evidence for disorder-specific dys-\",\n",
            "  \"163\": \"function, such as during tasks assessing attention deployment in response to emotional\",\n",
            "  \"164\": \"stimuli, which has demonstrated unique signs of dysfunction in children with chronic ir-\",\n",
            "  \"165\": \"ritability.\",\n",
            "  \"166\": \"Gender-Related Diagnostic Issues\",\n",
            "  \"167\": \"Children presenting to clinics with features of disruptive mood dysregulation disorder are\",\n",
            "  \"168\": \"predominantly male. Among community samples, a male preponderance appears to be\",\n",
            "  \"169\": \"supported. This difference in prevalence between males and females differentiates disrup-\",\n",
            "  \"170\": \"tive mood dysregulation disorder from bipolar disorder, in which there is an equal gender\",\n",
            "  \"171\": \"prevalence.\",\n",
            "  \"172\": \"Suicide Risk\",\n",
            "  \"173\": \"In general, evidence documenting suicidal behavior and aggression, as well as other se-\",\n",
            "  \"174\": \"vere functional consequences, in disruptive mood dysregulation disorder should be noted\",\n",
            "  \"175\": \"when evaluating children with chronic irritability.\",\n",
            "  \"176\": \"Functional Consequences of\",\n",
            "  \"177\": \"Disruptive Mood Dysregulation Disorder\",\n",
            "  \"178\": \"Chronic, severe irritability, such as is seen in disruptive mood dysregulation disorder, is\",\n",
            "  \"179\": \"associated with marked disruption in a child\\u2019s family and peer relationships, as well as in\",\n",
            "  \"180\": \"school performance. Because of their extremely low frustration tolerance, such children\",\n",
            "  \"181\": \"generally have difficulty succeeding in school; they are often unable to participate in the\",\n",
            "  \"182\": \"activities typically enjoyed by healthy children; their family life is severely disrupted by\",\n",
            "  \"183\": \"their outbursts and irritability; and they have trouble initiating or sustaining friendships.\",\n",
            "  \"184\": \"Levels of dysfunction in children with bipolar disorder and disruptive mood dysregulation\",\n",
            "  \"185\": \"disorder are generally comparable. Both conditions cause severe disruption in the lives of\",\n",
            "  \"186\": \"the affected individual and their families. In both disruptive mood dysregulation disorder\",\n",
            "  \"187\": \"and pediatric bipolar disorder, dangerous behavior, suicidal ideation or suicide attempts,\",\n",
            "  \"188\": \"severe aggression, and psychiatric hospitalization are common.\",\n",
            "  \"189\": \"Differential Diagnosis\",\n",
            "  \"190\": \"Because chronically irritable children and adolescents typically present with complex histo-\",\n",
            "  \"191\": \"ries, the diagnosis of disruptive mood dysregulation disorder must be made while consid-\",\n",
            "  \"192\": \"ering the presence or absence of multiple other conditions. Despite the need to consider\",\n",
            "  \"193\": \"Disruptive Mood Dysregulation Disorder 159\",\n",
            "  \"194\": \"many other syndromes, differentiation of disruptive mood dysregulation disorder from bi-\",\n",
            "  \"195\": \"polar disorder and oppositional defiant disorder requires particularly careful assessment.\",\n",
            "  \"196\": \"Bipolar disorders. The central feature differentiating disruptive mood dysregulation disor-\",\n",
            "  \"197\": \"der and bipolar disorders in children involves the longitudinal course of the core symptoms. In\",\n",
            "  \"198\": \"children, as in adults, bipolar I disorder and bipolar II disorder manifest as an episodic illness\",\n",
            "  \"199\": \"with discrete episodes of mood perturbation that can be differentiated from the child\\u2019s typical\",\n",
            "  \"200\": \"presentation. The mood perturbation that occurs during a manic episode is distinctly different\",\n",
            "  \"201\": \"from the child\\u2019s usual mood. In addition, during a manic episode, the change in mood must be\",\n",
            "  \"202\": \"accompanied by the onset, or worsening, of associated cognitive, behavioral, and physical\",\n",
            "  \"203\": \"symptoms (e.g., distractibility, increased goal-directed activity), which are also present to a de-\",\n",
            "  \"204\": \"gree that is distinctly different from the child\\u2019s usual baseline. Thus, in the case of a manic ep-\",\n",
            "  \"205\": \"isode, parents (and, depending on developmental level, children) should be able to identify a\",\n",
            "  \"206\": \"distinct time period during which the child\\u2019s mood and behavior were markedly different\",\n",
            "  \"207\": \"from usual. In contrast, the irritability of disruptive mood dysregulation disorder is persistent\",\n",
            "  \"208\": \"and is present over many months; while it may wax and wane to a certain degree, severe irri-\",\n",
            "  \"209\": \"tability is characteristic of the child with disruptive mood dysregulation disorder. Thus, while\",\n",
            "  \"210\": \"bipolar disorders are episodic conditions, disruptive mood dysregulation disorder is not. In\",\n",
            "  \"211\": \"fact, the diagnosis of disruptive mood dysregulation disorder cannot be assigned to a child\",\n",
            "  \"212\": \"who has ever experienced a full-duration hypomanic or manic episode (irritable or euphoric)\",\n",
            "  \"213\": \"or who has ever had a manic or hypomanic episode lasting more than 1 day. Another central\",\n",
            "  \"214\": \"differentiating feature between bipolar disorders and disruptive mood dysregulation disorder\",\n",
            "  \"215\": \"is the presence of elevated or expansive mood and grandiosity. These symptoms are common\",\n",
            "  \"216\": \"features of mania but are not characteristic of disruptive mood dysregulation disorder.\",\n",
            "  \"217\": \"Oppositional defiant disorder. While symptoms of oppositional defiant disorder typi-\",\n",
            "  \"218\": \"cally do occur in children with disruptive mood dysregulation disorder, mood symptoms\",\n",
            "  \"219\": \"of disruptive mood dysregulation disorder are relatively rare in children with opposi-\",\n",
            "  \"220\": \"tional defiant disorder. The key features that warrant the diagnosis of disruptive mood\",\n",
            "  \"221\": \"dysregulation disorder in children whose symptoms also meet criteria for oppositional de-\",\n",
            "  \"222\": \"fiant disorder are the presence of severe and frequently recurrent outbursts and a persis-\",\n",
            "  \"223\": \"tent disruption in mood between outbursts. In addition, the diagnosis of disruptive mood\",\n",
            "  \"224\": \"dysregulation disorder requires severe impairment in at least one setting (i.e., home,\",\n",
            "  \"225\": \"school, or among peers) and mild to moderate impairment in a second setting. For this rea-\",\n",
            "  \"226\": \"son, while most children whose symptoms meet criteria for disruptive mood dysregula-\",\n",
            "  \"227\": \"tion disorder will also have a presentation that meets criteria for oppositional defiant\",\n",
            "  \"228\": \"disorder, the reverse is not the case. That is, in only approximately 15% of individuals with\",\n",
            "  \"229\": \"oppositional defiant disorder would criteria for disruptive mood dysregulation disorder\",\n",
            "  \"230\": \"be met. Moreover, even for children in whom criteria for both disorders are met, only the\",\n",
            "  \"231\": \"diagnosis of disruptive mood dysregulation disorder should be made. Finally, both the\",\n",
            "  \"232\": \"prominent mood symptoms in disruptive mood dysregulation disorder and the high risk\",\n",
            "  \"233\": \"for depressive and anxiety disorders in follow-up studies justify placement of disruptive\",\n",
            "  \"234\": \"mood dysregulation disorder among the depressive disorders in DSM-5. (Oppositional\",\n",
            "  \"235\": \"defiant disorder is included in the chapter \\u201cDisruptive, Impulse-Control, and Conduct\",\n",
            "  \"236\": \"Disorders.\\u201d) This reflects the more prominent mood component among individuals with\",\n",
            "  \"237\": \"disruptive mood dysregulation disorder, as compared with individuals with oppositional\",\n",
            "  \"238\": \"defiant disorder. Nevertheless, it also should be noted that disruptive mood dysregulation\",\n",
            "  \"239\": \"disorder appears to carry a high risk for behavioral problems as well as mood problems.\",\n",
            "  \"240\": \"Attention-deficit/hyperactivity disorder, major depressive disorder, anxiety disorders,\",\n",
            "  \"241\": \"and autism spectrum disorder. Unlike children diagnosed with bipolar disorder or op-\",\n",
            "  \"242\": \"positional defiant disorder, a child whose symptoms meet criteria for disruptive mood\",\n",
            "  \"243\": \"dysregulation disorder also can receive a comorbid diagnosis of ADHD, major depressive\",\n",
            "  \"244\": \"disorder, and/or anxiety disorder. However, children whose irritability is present only in\",\n",
            "  \"245\": \"the context of a major depressive episode or persistent depressive disorder (dysthymia)\",\n",
            "  \"1.246\": \"Depressive Disorders\",\n",
            "  \"247\": \"should receive one of those diagnoses rather than disruptive mood dysregulation disor-\",\n",
            "  \"248\": \"der. Children with disruptive mood dysregulation disorder may have symptoms that also\",\n",
            "  \"249\": \"meet criteria for an anxiety disorder and can receive both diagnoses, but children whose ir-\",\n",
            "  \"250\": \"ritability is manifest only in the context of exacerbation of an anxiety disorder should re-\",\n",
            "  \"251\": \"ceive the relevant anxiety disorder diagnosis rather than disruptive mood dysregulation\",\n",
            "  \"252\": \"disorder. In addition, children with autism spectrum disorders frequently present with\",\n",
            "  \"253\": \"temper outbursts when, for example, their routines are disturbed. In that instance, the\",\n",
            "  \"254\": \"temper outbursts would be considered secondary to the autism spectrum disorder, and\",\n",
            "  \"255\": \"the child should not receive the diagnosis of disruptive mood dysregulation disorder.\",\n",
            "  \"256\": \"Intermittent explosive disorder. Children with symptoms suggestive of intermittent\",\n",
            "  \"257\": \"explosive disorder present with instances of severe temper outbursts, much like children\",\n",
            "  \"258\": \"with disruptive mood dysregulation disorder. However, unlike disruptive mood dysreg-\",\n",
            "  \"259\": \"ulation disorder, intermittent explosive disorder does not require persistent disruption in\",\n",
            "  \"260\": \"mood between outbursts. In addition, intermittent explosive disorder requires only 3 months\",\n",
            "  \"261\": \"of active symptoms, in contrast to the 12-month requirement for disruptive mood dys-\",\n",
            "  \"262\": \"regulation disorder. Thus, these two diagnoses should not be made in the same child. For\",\n",
            "  \"263\": \"children with outbursts and intercurrent, persistent irritability, only the diagnosis of dis-\",\n",
            "  \"264\": \"ruptive mood dysregulation disorder should be made.\",\n",
            "  \"265\": \"Comorbidity\",\n",
            "  \"266\": \"Rates of comorbidity in disruptive mood dysregulation disorder are extremely high. It is\",\n",
            "  \"267\": \"rare to find individuals whose symptoms meet criteria for disruptive mood dysregulation\",\n",
            "  \"268\": \"disorder alone. Comorbidity between disruptive mood dysregulation disorder and other\",\n",
            "  \"269\": \"DSM-defined syndromes appears higher than for many other pediatric mental illnesses;\",\n",
            "  \"270\": \"the strongest overlap is with oppositional defiant disorder. Not only is the overall rate of\",\n",
            "  \"271\": \"comorbidity high in disruptive mood dysregulation disorder, but also the range of comor-\",\n",
            "  \"272\": \"bid illnesses appears particularly diverse. These children typically present to the clinic\",\n",
            "  \"273\": \"with a wide range of disruptive behavior, mood, anxiety, and even autism spectrum\",\n",
            "  \"274\": \"symptoms and diagnoses. However, children with disruptive mood dysregulation disor-\",\n",
            "  \"275\": \"der should not have symptoms that meet criteria for bipolar disorder, as in that context,\",\n",
            "  \"276\": \"only the bipolar disorder diagnosis should be made. If children have symptoms that meet\",\n",
            "  \"277\": \"criteria for oppositional defiant disorder or intermittent explosive disorder and disruptive\",\n",
            "  \"278\": \"mood dysregulation disorder, only the diagnosis of disruptive mood dysregulation disor-\",\n",
            "  \"279\": \"der should be assigned. Also, as noted earlier, the diagnosis of disruptive mood dysregu-\",\n",
            "  \"280\": \"lation disorder should not be assigned if the symptoms occur only in an anxiety-\",\n",
            "  \"281\": \"provoking context, when the routines of a child with autism spectrum disorder or obses-\",\n",
            "  \"282\": \"sive-compulsive disorder are disturbed, or in the context of a major depressive episode.\",\n",
            "  \"283\": \"Major Depressive Disorder\",\n",
            "  \"284\": \"Diagnostic Criteria\",\n",
            "  \"285\": \"A. Five (or more) of the following symptoms have been present during the same 2-week\",\n",
            "  \"286\": \"period and represent a change from previous functioning; at least one of the symptoms\",\n",
            "  \"287\": \"is either (1) depressed mood or (2) loss of interest or pleasure.\",\n",
            "  \"288\": \"Note: Do not include symptoms that are clearly attributable to another medical condition.\",\n",
            "  \"289\": \"1. Depressed mood most of the day, nearly every day, as indicated by either subjec-\",\n",
            "  \"290\": \"tive report (e.g., feels sad, empty, hopeless) or observation made by others (e.g.,\",\n",
            "  \"291\": \"appears tearful). (Note: In children and adolescents, can be irritable mood.)\",\n",
            "  \"292\": \"2. Markedly diminished interest or pleasure in all, or almost all, activities most of the\",\n",
            "  \"293\": \"day, nearly every day (as indicated by either subjective account or observation).\",\n",
            "  \"294\": \"Major Depressive Disorder 161\",\n",
            "  \"295\": \"3. Significant weight loss when not dieting or weight gain (e.g., a change of more than\",\n",
            "  \"296\": \"5% of body weight in a month), or decrease or increase in appetite nearly every day.\",\n",
            "  \"297\": \"(Note: In children, consider failure to make expected weight gain.)\",\n",
            "  \"298\": \"4. Insomnia or hypersomnia nearly every day.\",\n",
            "  \"299\": \"5. Psychomotor agitation or retardation nearly every day (observable by others, not\",\n",
            "  \"300\": \"merely subjective feelings of restlessness or being slowed down).\",\n",
            "  \"301\": \"6. Fatigue or loss of energy nearly every day.\",\n",
            "  \"302\": \"7. Feelings of worthlessness or excessive or inappropriate guilt (which may be delu-\",\n",
            "  \"303\": \"sional) nearly every day (not merely self-reproach or guilt about being sick).\",\n",
            "  \"304\": \"8. Diminished ability to think or concentrate, or indecisiveness, nearly every day (ei-\",\n",
            "  \"305\": \"ther by subjective account or as observed by others).\",\n",
            "  \"306\": \"9. Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation with-\",\n",
            "  \"307\": \"out a specific plan, or a suicide attempt or a specific plan for committing suicide.\",\n",
            "  \"308\": \"B. The symptoms cause clinically significant distress or impairment in social, occupa-\",\n",
            "  \"309\": \"tional, or other important areas of functioning.\",\n",
            "  \"310\": \"C. The episode is not attributable to the physiological effects of a substance or to another\",\n",
            "  \"311\": \"medical condition.\",\n",
            "  \"312\": \"Note: Criteria A\\u2013C represent a major depressive episode.\",\n",
            "  \"313\": \"Note: Responses to a significant loss (e.g., bereavement, financial ruin, losses from a nat-\",\n",
            "  \"314\": \"ural disaster, a serious medical illness or disability) may include the feelings of intense sad-\",\n",
            "  \"315\": \"ness, rumination about the loss, insomnia, poor appetite, and weight loss noted in Criterion A,\",\n",
            "  \"316\": \"which may resemble a depressive episode. Although such symptoms may be understand-\",\n",
            "  \"317\": \"able or considered appropriate to the loss, the presence of a major depressive episode in\",\n",
            "  \"318\": \"addition to the normal response to a significant loss should also be carefully considered. This\",\n",
            "  \"319\": \"decision inevitably requires the exercise of clinical judgment based on the individual\\u2019s history\",\n",
            "  \"320\": \"and the cultural norms for the expression of distress in the context of loss.1\",\n",
            "  \"321\": \"D. The occurrence of the major depressive episode is not better explained by schizoaf-\",\n",
            "  \"322\": \"fective disorder, schizophrenia, schizophreniform disorder, delusional disorder, or\",\n",
            "  \"323\": \"other specified and unspecified schizophrenia spectrum and other psychotic disorders.\",\n",
            "  \"324\": \"E. There has never been a manic episode or a hypomanic episode.\",\n",
            "  \"325\": \"Note: This exclusion does not apply if all of the manic-like or hypomanic-like episodes\",\n",
            "  \"326\": \"are substance-induced or are attributable to the physiological effects of another med-\",\n",
            "  \"327\": \"ical condition.\",\n",
            "  \"328\": \"1In distinguishing grief from a major depressive episode (MDE), it is useful to consider that in\",\n",
            "  \"329\": \"grief the predominant affect is feelings of emptiness and loss, while in MDE it is persistent\",\n",
            "  \"330\": \"depressed mood and the inability to anticipate happiness or pleasure. The dysphoria in grief is\",\n",
            "  \"331\": \"likely to decrease in intensity over days to weeks and occurs in waves, the so-called pangs of\",\n",
            "  \"332\": \"grief. These waves tend to be associated with thoughts or reminders of the deceased. The\",\n",
            "  \"333\": \"depressed mood of MDE is more persistent and not tied to specific thoughts or preoccupations.\",\n",
            "  \"334\": \"The pain of grief may be accompanied by positive emotions and humor that are uncharacteristic\",\n",
            "  \"335\": \"of the pervasive unhappiness and misery characteristic of MDE. The thought content associated\",\n",
            "  \"336\": \"with grief generally features a preoccupation with thoughts and memories of the deceased,\",\n",
            "  \"337\": \"rather than the self-critical or pessimistic ruminations seen in MDE. In grief, self-esteem is gener-\",\n",
            "  \"338\": \"ally preserved, whereas in MDE feelings of worthlessness and self-loathing are common. If self-\",\n",
            "  \"339\": \"derogatory ideation is present in grief, it typically involves perceived failings vis-\\u00e0-vis the\",\n",
            "  \"340\": \"deceased (e.g., not visiting frequently enough, not telling the deceased how much he or she was\",\n",
            "  \"341\": \"loved). If a bereaved individual thinks about death and dying, such thoughts are generally\",\n",
            "  \"342\": \"focused on the deceased and possibly about \\u201cjoining\\u201d the deceased, whereas in MDE such\",\n",
            "  \"343\": \"thoughts are focused on ending one\\u2019s own life because of feeling worthless, undeserving of life,\",\n",
            "  \"344\": \"or unable to cope with the pain of depression.\",\n",
            "  \"1.345\": \"Depressive Disorders\",\n",
            "  \"346\": \"Coding and Recording Procedures\",\n",
            "  \"347\": \"The diagnostic code for major depressive disorder is based on whether this is a single or\",\n",
            "  \"348\": \"recurrent episode, current severity, presence of psychotic features, and remission status.\",\n",
            "  \"349\": \"Current severity and psychotic features are only indicated if full criteria are currently met\",\n",
            "  \"350\": \"for a major depressive episode. Remission specifiers are only indicated if the full criteria\",\n",
            "  \"351\": \"are not currently met for a major depressive episode. Codes are as follows:\",\n",
            "  \"352\": \"Severity/course specifier Single episode Recurrent episode*\",\n",
            "  \"353\": \"Mild (p. 188) 296.21 (F32.0) 296.31 (F33.0)\",\n",
            "  \"354\": \"Moderate (p. 188) 296.22 (F32.1) 296.32 (F33.1)\",\n",
            "  \"355\": \"Severe (p. 188) 296.23 (F32.2) 296.33 (F33.2)\",\n",
            "  \"356\": \"With psychotic features** (p. 186) 296.24 (F32.3) 296.34 (F33.3)\",\n",
            "  \"357\": \"In partial remission (p. 188) 296.25 (F32.4) 296.35 (F33.41)\",\n",
            "  \"358\": \"In full remission (p. 188) 296.26 (F32.5) 296.36 (F33.42)\",\n",
            "  \"359\": \"Unspecified 296.20 (F32.9) 296.30 (F33.9)\",\n",
            "  \"360\": \"*For an episode to be considered recurrent, there must be an interval of at least 2 consecutive months\",\n",
            "  \"361\": \"between separate episodes in which criteria are not met for a major depressive episode. The defini-\",\n",
            "  \"362\": \"tions of specifiers are found on the indicated pages.\",\n",
            "  \"363\": \"**If psychotic features are present, code the \\u201cwith psychotic features\\u201d specifier irrespective of epi-\",\n",
            "  \"364\": \"sode severity.\",\n",
            "  \"365\": \"In recording the name of a diagnosis, terms should be listed in the following order: major\",\n",
            "  \"366\": \"depressive disorder, single or recurrent episode, severity/psychotic/remission specifiers,\",\n",
            "  \"367\": \"followed by as many of the following specifiers without codes that apply to the current\",\n",
            "  \"368\": \"episode.\",\n",
            "  \"369\": \"Specify:\",\n",
            "  \"370\": \"With anxious distress (p. 184)\",\n",
            "  \"371\": \"With mixed features (pp. 184\\u2013185)\",\n",
            "  \"372\": \"With melancholic features (p. 185)\",\n",
            "  \"373\": \"With atypical features (pp. 185\\u2013186)\",\n",
            "  \"374\": \"With mood-congruent psychotic features (p. 186)\",\n",
            "  \"375\": \"With mood-incongruent psychotic features (p. 186)\",\n",
            "  \"376\": \"With catatonia (p. 186). Coding note: Use additional code 293.89 (F06.1).\",\n",
            "  \"377\": \"With peripartum onset (pp. 186\\u2013187)\",\n",
            "  \"378\": \"With seasonal pattern (recurrent episode only) (pp. 187\\u2013188)\",\n",
            "  \"379\": \"Diagnostic Features\",\n",
            "  \"380\": \"The criterion symptoms for major depressive disorder must be present nearly every day to\",\n",
            "  \"381\": \"be considered present, with the exception of weight change and suicidal ideation. De-\",\n",
            "  \"382\": \"pressed mood must be present for most of the day, in addition to being present nearly ev-\",\n",
            "  \"383\": \"ery day. Often insomnia or fatigue is the presenting complaint, and failure to probe for\",\n",
            "  \"384\": \"accompanying depressive symptoms will result in underdiagnosis. Sadness may be de-\",\n",
            "  \"385\": \"nied at first but may be elicited through interview or inferred from facial expression and\",\n",
            "  \"386\": \"demeanor. With individuals who focus on a somatic complaint, clinicians should de-\",\n",
            "  \"387\": \"termine whether the distress from that complaint is associated with specific depressive\",\n",
            "  \"388\": \"symptoms. Fatigue and sleep disturbance are present in a high proportion of cases; psy-\",\n",
            "  \"389\": \"chomotor disturbances are much less common but are indicative of greater overall sever-\",\n",
            "  \"390\": \"ity, as is the presence of delusional or near-delusional guilt.\",\n",
            "  \"391\": \"Major Depressive Disorder 163\",\n",
            "  \"392\": \"The essential feature of a major depressive episode is a period of at least 2 weeks during\",\n",
            "  \"393\": \"which there is either depressed mood or the loss of interest or pleasure in nearly all activi-\",\n",
            "  \"394\": \"ties (Criterion A). In children and adolescents, the mood may be irritable rather than sad.\",\n",
            "  \"395\": \"The individual must also experience at least four additional symptoms drawn from a list\",\n",
            "  \"396\": \"that includes changes in appetite or weight, sleep, and psychomotor activity; decreased en-\",\n",
            "  \"397\": \"ergy; feelings of worthlessness or guilt; difficulty thinking, concentrating, or making deci-\",\n",
            "  \"398\": \"sions; or recurrent thoughts of death or suicidal ideation or suicide plans or attempts. To\",\n",
            "  \"399\": \"count toward a major depressive episode, a symptom must either be newly present or must\",\n",
            "  \"400\": \"have clearly worsened compared with the person\\u2019s pre-episode status. The symptoms\",\n",
            "  \"401\": \"must persist for most of the day, nearly every day, for at least 2 consecutive weeks. The ep-\",\n",
            "  \"402\": \"isode must be accompanied by clinically significant distress or impairment in social, occu-\",\n",
            "  \"403\": \"pational, or other important areas of functioning. For some individuals with milder\",\n",
            "  \"404\": \"episodes, functioning may appear to be normal but requires markedly increased effort.\",\n",
            "  \"405\": \"The mood in a major depressive episode is often described by the person as depressed,\",\n",
            "  \"406\": \"sad, hopeless, discouraged, or \\u201cdown in the dumps\\u201d (Criterion A1). In some cases, sadness\",\n",
            "  \"407\": \"may be denied at first but may subsequently be elicited by interview (e.g., by pointing out\",\n",
            "  \"408\": \"that the individual looks as if he or she is about to cry). In some individuals who complain\",\n",
            "  \"409\": \"of feeling \\u201cblah,\\u201d having no feelings, or feeling anxious, the presence of a depressed mood\",\n",
            "  \"410\": \"can be inferred from the person\\u2019s facial expression and demeanor. Some individuals em-\",\n",
            "  \"411\": \"phasize somatic complaints (e.g., bodily aches and pains) rather than reporting feelings of\",\n",
            "  \"412\": \"sadness. Many individuals report or exhibit increased irritability (e.g., persistent anger, a\",\n",
            "  \"413\": \"tendency to respond to events with angry outbursts or blaming others, an exaggerated\",\n",
            "  \"414\": \"sense of frustration over minor matters). In children and adolescents, an irritable or cranky\",\n",
            "  \"415\": \"mood may develop rather than a sad or dejected mood. This presentation should be dif-\",\n",
            "  \"416\": \"ferentiated from a pattern of irritability when frustrated.\",\n",
            "  \"417\": \"Loss of interest or pleasure is nearly always present, at least to some degree. Individ-\",\n",
            "  \"418\": \"uals may report feeling less interested in hobbies, \\u201cnot caring anymore,\\u201d or not feeling any\",\n",
            "  \"419\": \"enjoyment in activities that were previously considered pleasurable (Criterion A2). Family\",\n",
            "  \"420\": \"members often notice social withdrawal or neglect of pleasurable avocations (e.g., a for-\",\n",
            "  \"421\": \"merly avid golfer no longer plays, a child who used to enjoy soccer finds excuses not to\",\n",
            "  \"422\": \"practice). In some individuals, there is a significant reduction from previous levels of sex-\",\n",
            "  \"423\": \"ual interest or desire.\",\n",
            "  \"424\": \"Appetite change may involve either a reduction or increase. Some depressed individ-\",\n",
            "  \"425\": \"uals report that they have to force themselves to eat. Others may eat more and may crave\",\n",
            "  \"426\": \"specific foods (e.g., sweets or other carbohydrates). When appetite changes are severe (in\",\n",
            "  \"427\": \"either direction), there may be a significant loss or gain in weight, or, in children, a failure\",\n",
            "  \"428\": \"to make expected weight gains may be noted (Criterion A3).\",\n",
            "  \"429\": \"Sleep disturbance may take the form of either difficulty sleeping or sleeping exces-\",\n",
            "  \"430\": \"sively (Criterion A4). When insomnia is present, it typically takes the form of middle in-\",\n",
            "  \"431\": \"somnia (i.e., waking up during the night and then having difficulty returning to sleep) or\",\n",
            "  \"432\": \"terminal insomnia (i.e., waking too early and being unable to return to sleep). Initial in-\",\n",
            "  \"433\": \"somnia (i.e., difficulty falling asleep) may also occur. Individuals who present with over-\",\n",
            "  \"434\": \"sleeping (hypersomnia) may experience prolonged sleep episodes at night or increased\",\n",
            "  \"435\": \"daytime sleep. Sometimes the reason that the individual seeks treatment is for the dis-\",\n",
            "  \"436\": \"turbed sleep.\",\n",
            "  \"437\": \"Psychomotor changes include agitation (e.g., the inability to sit still, pacing, hand-\",\n",
            "  \"438\": \"wringing; or pulling or rubbing of the skin, clothing, or other objects) or retardation (e.g.,\",\n",
            "  \"439\": \"slowed speech, thinking, and body movements; increased pauses before answering;\",\n",
            "  \"440\": \"speech that is decreased in volume, inflection, amount, or variety of content, or muteness)\",\n",
            "  \"441\": \"(Criterion A5). The psychomotor agitation or retardation must be severe enough to be ob-\",\n",
            "  \"442\": \"servable by others and not represent merely subjective feelings.\",\n",
            "  \"443\": \"Decreased energy, tiredness, and fatigue are common (Criterion A6). A person may re-\",\n",
            "  \"444\": \"port sustained fatigue without physical exertion. Even the smallest tasks seem to require\",\n",
            "  \"1.445\": \"Depressive Disorders\",\n",
            "  \"446\": \"substantial effort. The efficiency with which tasks are accomplished may be reduced. For\",\n",
            "  \"447\": \"example, an individual may complain that washing and dressing in the morning are ex-\",\n",
            "  \"448\": \"hausting and take twice as long as usual.\",\n",
            "  \"449\": \"The sense of worthlessness or guilt associated with a major depressive episode may in-\",\n",
            "  \"450\": \"clude unrealistic negative evaluations of one\\u2019s worth or guilty preoccupations or rumina-\",\n",
            "  \"451\": \"tions over minor past failings (Criterion A7). Such individuals often misinterpret neutral\",\n",
            "  \"452\": \"or trivial day-to-day events as evidence of personal defects and have an exaggerated sense\",\n",
            "  \"453\": \"of responsibility for untoward events. The sense of worthlessness or guilt may be of delu-\",\n",
            "  \"454\": \"sional proportions (e.g., an individual who is convinced that he or she is personally re-\",\n",
            "  \"455\": \"sponsible for world poverty). Blaming oneself for being sick and for failing to meet\",\n",
            "  \"456\": \"occupational or interpersonal responsibilities as a result of the depression is very common\",\n",
            "  \"457\": \"and, unless delusional, is not considered sufficient to meet this criterion.\",\n",
            "  \"458\": \"Many individuals report impaired ability to think, concentrate, or make even minor\",\n",
            "  \"459\": \"decisions (Criterion A8). They may appear easily distracted or complain of memory diffi-\",\n",
            "  \"460\": \"culties. Those engaged in cognitively demanding pursuits are often unable to function. In\",\n",
            "  \"461\": \"children, a precipitous drop in grades may reflect poor concentration. In elderly individ-\",\n",
            "  \"462\": \"uals, memory difficulties may be the chief complaint and may be mistaken for early signs\",\n",
            "  \"463\": \"of a dementia (\\u201cpseudodementia\\u201d). When the major depressive episode is successfully\",\n",
            "  \"464\": \"treated, the memory problems often fully abate. However, in some individuals, particu-\",\n",
            "  \"465\": \"larly elderly persons, a major depressive episode may sometimes be the initial presenta-\",\n",
            "  \"466\": \"tion of an irreversible dementia.\",\n",
            "  \"467\": \"Thoughts of death, suicidal ideation, or suicide attempts (Criterion A9) are common.\",\n",
            "  \"468\": \"They may range from a passive wish not to awaken in the morning or a belief that others\",\n",
            "  \"469\": \"would be better off if the individual were dead, to transient but recurrent thoughts of com-\",\n",
            "  \"470\": \"mitting suicide, to a specific suicide plan. More severely suicidal individuals may have put\",\n",
            "  \"471\": \"their affairs in order (e.g., updated wills, settled debts), acquired needed materials (e.g., a\",\n",
            "  \"472\": \"rope or a gun), and chosen a location and time to accomplish the suicide. Motivations for\",\n",
            "  \"473\": \"suicide may include a desire to give up in the face of perceived insurmountable obstacles,\",\n",
            "  \"474\": \"an intense wish to end what is perceived as an unending and excruciatingly painful emo-\",\n",
            "  \"475\": \"tional state, an inability to foresee any enjoyment in life, or the wish to not be a burden to\",\n",
            "  \"476\": \"others. The resolution of such thinking may be a more meaningful measure of diminished\",\n",
            "  \"477\": \"suicide risk than denial of further plans for suicide.\",\n",
            "  \"478\": \"The evaluation of the symptoms of a major depressive episode is especially difficult\",\n",
            "  \"479\": \"when they occur in an individual who also has a general medical condition (e.g., cancer,\",\n",
            "  \"480\": \"stroke, myocardial infarction, diabetes, pregnancy). Some of the criterion signs and symp-\",\n",
            "  \"481\": \"toms of a major depressive episode are identical to those of general medical conditions\",\n",
            "  \"482\": \"(e.g., weight loss with untreated diabetes; fatigue with cancer; hypersomnia early in preg-\",\n",
            "  \"483\": \"nancy; insomnia later in pregnancy or the postpartum). Such symptoms count toward a\",\n",
            "  \"484\": \"major depressive diagnosis except when they are clearly and fully attributable to a general\",\n",
            "  \"485\": \"medical condition. Nonvegetative symptoms of dysphoria, anhedonia, guilt or worthless-\",\n",
            "  \"486\": \"ness, impaired concentration or indecision, and suicidal thoughts should be assessed with\",\n",
            "  \"487\": \"particular care in such cases. Definitions of major depressive episodes that have been mod-\",\n",
            "  \"488\": \"ified to include only these nonvegetative symptoms appear to identify nearly the same in-\",\n",
            "  \"489\": \"dividuals as do the full criteria.\",\n",
            "  \"490\": \"Associated Features Supporting Diagnosis\",\n",
            "  \"491\": \"Major depressive disorder is associated with high mortality, much of which is accounted\",\n",
            "  \"492\": \"for by suicide; however, it is not the only cause. For example, depressed individuals ad-\",\n",
            "  \"493\": \"mitted to nursing homes have a markedly increased likelihood of death in the first year. In-\",\n",
            "  \"494\": \"dividuals frequently present with tearfulness, irritability, brooding, obsessive rumination,\",\n",
            "  \"495\": \"anxiety, phobias, excessive worry over physical health, and complaints of pain (e.g., head-\",\n",
            "  \"496\": \"aches; joint, abdominal, or other pains). In children, separation anxiety may occur.\",\n",
            "  \"497\": \"Major Depressive Disorder 165\",\n",
            "  \"498\": \"Although an extensive literature exists describing neuroanatomical, neuroendocrino-\",\n",
            "  \"499\": \"logical, and neurophysiological correlates of major depressive disorder, no laboratory test\",\n",
            "  \"500\": \"has yielded results of sufficient sensitivity and specificity to be used as a diagnostic tool for\",\n",
            "  \"501\": \"this disorder. Until recently, hypothalamic-pituitary-adrenal axis hyperactivity had been\",\n",
            "  \"502\": \"the most extensively investigated abnormality associated with major depressive episodes,\",\n",
            "  \"503\": \"and it appears to be associated with melancholia, psychotic features, and risks for eventual\",\n",
            "  \"504\": \"suicide. Molecular studies have also implicated peripheral factors, including genetic vari-\",\n",
            "  \"505\": \"ants in neurotrophic factors and pro-inflammatory cytokines. Additionally, functional\",\n",
            "  \"506\": \"magnetic resonance imaging studies provide evidence for functional abnormalities in spe-\",\n",
            "  \"507\": \"cific neural systems supporting emotion processing, reward seeking, and emotion regula-\",\n",
            "  \"508\": \"tion in adults with major depression.\",\n",
            "  \"509\": \"Prevalence\",\n",
            "  \"510\": \"Twelve-month prevalence of major depressive disorder in the United States is approximately\",\n",
            "  \"511\": \"7%, with marked differences by age group such that the prevalence in 18- to 29-year-old indi-\",\n",
            "  \"512\": \"viduals is threefold higher than the prevalence in individuals age 60 years or older. Females ex-\",\n",
            "  \"513\": \"perience 1.5- to 3-fold higher rates than males beginning in early adolescence.\",\n",
            "  \"514\": \"Development and Course\",\n",
            "  \"515\": \"Major depressive disorder may first appear at any age, but the likelihood of onset in-\",\n",
            "  \"516\": \"creases markedly with puberty. In the United States, incidence appears to peak in the 20s;\",\n",
            "  \"517\": \"however, first onset in late life is not uncommon.\",\n",
            "  \"518\": \"The course of major depressive disorder is quite variable, such that some individuals\",\n",
            "  \"519\": \"rarely, if ever, experience remission (a period of 2 or more months with no symptoms, or\",\n",
            "  \"520\": \"only one or two symptoms to no more than a mild degree), while others experience many\",\n",
            "  \"521\": \"years with few or no symptoms between discrete episodes. It is important to distinguish\",\n",
            "  \"522\": \"individuals who present for treatment during an exacerbation of a chronic depressive ill-\",\n",
            "  \"523\": \"ness from those whose symptoms developed recently. Chronicity of depressive symptoms\",\n",
            "  \"524\": \"substantially increases the likelihood of underlying personality, anxiety, and substance\",\n",
            "  \"525\": \"use disorders and decreases the likelihood that treatment will be followed by full symp-\",\n",
            "  \"526\": \"tom resolution. It is therefore useful to ask individuals presenting with depressive symp-\",\n",
            "  \"527\": \"toms to identify the last period of at least 2 months during which they were entirely free of\",\n",
            "  \"528\": \"depressive symptoms.\",\n",
            "  \"529\": \"Recovery typically begins within 3 months of onset for two in five individuals with ma-\",\n",
            "  \"530\": \"jor depression and within 1 year for four in five individuals. Recency of onset is a strong\",\n",
            "  \"531\": \"determinant of the likelihood of near-term recovery, and many individuals who have been\",\n",
            "  \"532\": \"depressed only for several months can be expected to recover spontaneously. Features as-\",\n",
            "  \"533\": \"sociated with lower recovery rates, other than current episode duration, include psychotic\",\n",
            "  \"534\": \"features, prominent anxiety, personality disorders, and symptom severity.\",\n",
            "  \"535\": \"The risk of recurrence becomes progessively lower over time as the duration of re-\",\n",
            "  \"536\": \"mission increases. The risk is higher in individuals whose preceding episode was severe,\",\n",
            "  \"537\": \"in younger individuals, and in individuals who have already experienced multiple epi-\",\n",
            "  \"538\": \"sodes. The persistence of even mild depressive symptoms during remission is a powerful\",\n",
            "  \"539\": \"predictor of recurrence.\",\n",
            "  \"540\": \"Many bipolar illnesses begin with one or more depressive episodes, and a substantial\",\n",
            "  \"541\": \"proportion of individuals who initially appear to have major depressive disorder will\",\n",
            "  \"542\": \"prove, in time, to instead have a bipolar disorder. This is more likely in individuals with\",\n",
            "  \"543\": \"onset of the illness in adolescence, those with psychotic features, and those with a family\",\n",
            "  \"544\": \"history of bipolar illness. The presence of a \\u201cwith mixed features\\u201d specifier also increases\",\n",
            "  \"545\": \"the risk for future manic or hypomanic diagnosis. Major depressive disorder, particularly\",\n",
            "  \"546\": \"with psychotic features, may also transition into schizophrenia, a change that is much\",\n",
            "  \"547\": \"more frequent than the reverse.\",\n",
            "  \"1.548\": \"Depressive Disorders\",\n",
            "  \"549\": \"Despite consistent differences between genders in prevalence rates for depressive disor-\",\n",
            "  \"550\": \"ders, there appear to be no clear differences by gender in phenomenology, course, or treat-\",\n",
            "  \"551\": \"ment response. Similarly, there are no clear effects of current age on the course or treatment\",\n",
            "  \"552\": \"response of major depressive disorder. Some symptom differences exist, though, such that\",\n",
            "  \"553\": \"hypersomnia and hyperphagia are more likely in younger individuals, and melancholic\",\n",
            "  \"554\": \"symptoms, particularly psychomotor disturbances, are more common in older individuals.\",\n",
            "  \"555\": \"The likelihood of suicide attempts lessens in middle and late life, although the risk of com-\",\n",
            "  \"556\": \"pleted suicide does not. Depressions with earlier ages at onset are more familial and more\",\n",
            "  \"557\": \"likely to involve personality disturbances. The course of major depressive disorder within\",\n",
            "  \"558\": \"individuals does not generally change with aging. Mean times to recovery appear to be sta-\",\n",
            "  \"559\": \"ble over long periods, and the likelihood of being in an episode does not generally increase\",\n",
            "  \"560\": \"or decrease with time.\",\n",
            "  \"561\": \"Risk and Prognostic Factors\",\n",
            "  \"562\": \"Temperamental. Neuroticism (negative affectivity) is a well-established risk factor for the\",\n",
            "  \"563\": \"onset of major depressive disorder, and high levels appear to render individuals more likely\",\n",
            "  \"564\": \"to develop depressive episodes in response to stressful life events.\",\n",
            "  \"565\": \"Environmental. Adverse childhood experiences, particularly when there are multiple\",\n",
            "  \"566\": \"experiences of diverse types, constitute a set of potent risk factors for major depressive dis-\",\n",
            "  \"567\": \"order. Stressful life events are well recognized as precipitants of major depressive epi-\",\n",
            "  \"568\": \"sodes, but the presence or absence of adverse life events near the onset of episodes does\",\n",
            "  \"569\": \"not appear to provide a useful guide to prognosis or treatment selection.\",\n",
            "  \"570\": \"Genetic and physiological. First-degree family members of individuals with major de-\",\n",
            "  \"571\": \"pressive disorder have a risk for major depressive disorder two- to fourfold higher than\",\n",
            "  \"572\": \"that of the general population. Relative risks appear to be higher for early-onset and re-\",\n",
            "  \"573\": \"current forms. Heritability is approximately 40%, and the personality trait neuroticism ac-\",\n",
            "  \"574\": \"counts for a substantial portion of this genetic liability.\",\n",
            "  \"575\": \"Course modifiers. Essentially all major nonmood disorders increase the risk of an indi-\",\n",
            "  \"576\": \"vidual developing depression. Major depressive episodes that develop against the back-\",\n",
            "  \"577\": \"ground of another disorder often follow a more refractory course. Substance use, anxiety,\",\n",
            "  \"578\": \"and borderline personality disorders are among the most common of these, and the pre-\",\n",
            "  \"579\": \"senting depressive symptoms may obscure and delay their recognition. However, sus-\",\n",
            "  \"580\": \"tained clinical improvement in depressive symptoms may depend on the appropriate\",\n",
            "  \"581\": \"treatment of underlying illnesses. Chronic or disabling medical conditions also increase\",\n",
            "  \"582\": \"risks for major depressive episodes. Such prevalent illnesses as diabetes, morbid obesity,\",\n",
            "  \"583\": \"and cardiovascular disease are often complicated by depressive episodes, and these epi-\",\n",
            "  \"584\": \"sodes are more likely to become chronic than are depressive episodes in medically healthy\",\n",
            "  \"585\": \"individuals.\",\n",
            "  \"586\": \"Culture-Related Diagnostic Issues\",\n",
            "  \"587\": \"Surveys of major depressive disorder across diverse cultures have shown sevenfold dif-\",\n",
            "  \"588\": \"ferences in 12-month prevalence rates but much more consistency in female-to-male ratio,\",\n",
            "  \"589\": \"mean ages at onset, and the degree to which presence of the disorder raises the likelihood\",\n",
            "  \"590\": \"of comorbid substance abuse. While these findings suggest substantial cultural differences\",\n",
            "  \"591\": \"in the expression of major depressive disorder, they do not permit simple linkages be-\",\n",
            "  \"592\": \"tween particular cultures and the likelihood of specific symptoms. Rather, clinicians\",\n",
            "  \"593\": \"should be aware that in most countries the majority of cases of depression go unrecog-\",\n",
            "  \"594\": \"nized in primary care settings and that in many cultures, somatic symptoms are very likely\",\n",
            "  \"595\": \"to constitute the presenting complaint. Among the Criterion A symptoms, insomnia and\",\n",
            "  \"596\": \"loss of energy are the most uniformly reported.\",\n",
            "  \"597\": \"Major Depressive Disorder 167\",\n",
            "  \"598\": \"Gender-Related Diagnostic Issues\",\n",
            "  \"599\": \"Although the most reproducible finding in the epidemiology of major depressive disorder\",\n",
            "  \"600\": \"has been a higher prevalence in females, there are no clear differences between genders in\",\n",
            "  \"601\": \"symptoms, course, treatment response, or functional consequences. In women, the risk for\",\n",
            "  \"602\": \"suicide attempts is higher, and the risk for suicide completion is lower. The disparity in\",\n",
            "  \"603\": \"suicide rate by gender is not as great among those with depressive disorders as it is in the\",\n",
            "  \"604\": \"population as a whole.\",\n",
            "  \"605\": \"Suicide Risk\",\n",
            "  \"606\": \"The possibility of suicidal behavior exists at all times during major depressive episodes.\",\n",
            "  \"607\": \"The most consistently described risk factor is a past history of suicide attempts or threats,\",\n",
            "  \"608\": \"but it should be remembered that most completed suicides are not preceded by unsuccess-\",\n",
            "  \"609\": \"ful attempts. Other features associated with an increased risk for completed suicide\",\n",
            "  \"610\": \"include male sex, being single or living alone, and having prominent feelings of hopeless-\",\n",
            "  \"611\": \"ness. The presence of borderline personality disorder markedly increases risk for future\",\n",
            "  \"612\": \"suicide attempts.\",\n",
            "  \"613\": \"Functional Consequences of\",\n",
            "  \"614\": \"Major Depressive Disorder\",\n",
            "  \"615\": \"Many of the functional consequences of major depressive disorder derive from individual\",\n",
            "  \"616\": \"symptoms. Impairment can be very mild, such that many of those who interact with the af-\",\n",
            "  \"617\": \"fected individual are unaware of depressive symptoms. Impairment may, however, range\",\n",
            "  \"618\": \"to complete incapacity such that the depressed individual is unable to attend to basic self-\",\n",
            "  \"619\": \"care needs or is mute or catatonic. Among individuals seen in general medical settings,\",\n",
            "  \"620\": \"those with major depressive disorder have more pain and physical illness and greater de-\",\n",
            "  \"621\": \"creases in physical, social, and role functioning.\",\n",
            "  \"622\": \"Differential Diagnosis\",\n",
            "  \"623\": \"Manic episodes with irritable mood or mixed episodes. Major depressive episodes\",\n",
            "  \"624\": \"with prominent irritable mood may be difficult to distinguish from manic episodes with\",\n",
            "  \"625\": \"irritable mood or from mixed episodes. This distinction requires a careful clinical evalua-\",\n",
            "  \"626\": \"tion of the presence of manic symptoms.\",\n",
            "  \"627\": \"Mood disorder due to another medical condition. A major depressive episode is the\",\n",
            "  \"628\": \"appropriate diagnosis if the mood disturbance is not judged, based on individual history,\",\n",
            "  \"629\": \"physical examination, and laboratory findings, to be the direct pathophysiological conse-\",\n",
            "  \"630\": \"quence of a specific medical condition (e.g., multiple sclerosis, stroke, hypothyroidism).\",\n",
            "  \"631\": \"Substance/medication-induced depressive or bipolar disorder. This disorder is distin-\",\n",
            "  \"632\": \"guished from major depressive disorder by the fact that a substance (e.g., a drug of abuse,\",\n",
            "  \"633\": \"a medication, a toxin) appears to be etiologically related to the mood disturbance. For ex-\",\n",
            "  \"634\": \"ample, depressed mood that occurs only in the context of withdrawal from cocaine would\",\n",
            "  \"635\": \"be diagnosed as cocaine-induced depressive disorder.\",\n",
            "  \"636\": \"Attention-deficit/hyperactivity disorder. Distractibility and low frustration tolerance\",\n",
            "  \"637\": \"can occur in both attention-deficit/ hyperactivity disorder and a major depressive epi-\",\n",
            "  \"638\": \"sode; if the criteria are met for both, attention-deficit/hyperactivity disorder may be diag-\",\n",
            "  \"639\": \"nosed in addition to the mood disorder. However, the clinician must be cautious not to\",\n",
            "  \"640\": \"overdiagnose a major depressive episode in children with attention-deficit/hyperactivity\",\n",
            "  \"641\": \"disorder whose disturbance in mood is characterized by irritability rather than by sadness\",\n",
            "  \"642\": \"or loss of interest.\",\n",
            "  \"1.643\": \"Depressive Disorders\",\n",
            "  \"644\": \"Adjustment disorder with depressed mood. A major depressive episode that occurs in\",\n",
            "  \"645\": \"response to a psychosocial stressor is distinguished from adjustment disorder with de-\",\n",
            "  \"646\": \"pressed mood by the fact that the full criteria for a major depressive episode are not met in\",\n",
            "  \"647\": \"adjustment disorder.\",\n",
            "  \"648\": \"Sadness. Finally, periods of sadness are inherent aspects of the human experience.\",\n",
            "  \"649\": \"These periods should not be diagnosed as a major depressive episode unless criteria are\",\n",
            "  \"650\": \"met for severity (i.e., five out of nine symptoms), duration (i.e., most of the day, nearly ev-\",\n",
            "  \"651\": \"ery day for at least 2 weeks), and clinically significant distress or impairment. The diagno-\",\n",
            "  \"652\": \"sis other specified depressive disorder may be appropriate for presentations of depressed\",\n",
            "  \"653\": \"mood with clinically significant impairment that do not meet criteria for duration or se-\",\n",
            "  \"654\": \"verity.\",\n",
            "  \"655\": \"Comorbidity\",\n",
            "  \"656\": \"Other disorders with which major depressive disorder frequently co-occurs are substance-\",\n",
            "  \"657\": \"related disorders, panic disorder, obsessive-compulsive disorder, anorexia nervosa, buli-\",\n",
            "  \"658\": \"mia nervosa, and borderline personality disorder.\",\n",
            "  \"659\": \"Persistent Depressive Disorder (Dysthymia)\",\n",
            "  \"660\": \"Diagnostic Criteria 300.4 (F34.1)\",\n",
            "  \"661\": \"This disorder represents a consolidation of DSM-IV-defined chronic major depressive dis-\",\n",
            "  \"662\": \"order and dysthymic disorder.\",\n",
            "  \"663\": \"A. Depressed mood for most of the day, for more days than not, as indicated by either\",\n",
            "  \"664\": \"subjective account or observation by others, for at least 2 years.\",\n",
            "  \"665\": \"Note: In children and adolescents, mood can be irritable and duration must be at least\",\n",
            "  \"1.666\": \"year.\",\n",
            "  \"667\": \"B. Presence, while depressed, of two (or more) of the following:\",\n",
            "  \"668\": \"1. Poor appetite or overeating.\",\n",
            "  \"669\": \"2. Insomnia or hypersomnia.\",\n",
            "  \"670\": \"3. Low energy or fatigue.\",\n",
            "  \"671\": \"4. Low self-esteem.\",\n",
            "  \"672\": \"5. Poor concentration or difficulty making decisions.\",\n",
            "  \"673\": \"6. Feelings of hopelessness.\",\n",
            "  \"674\": \"C. During the 2-year period (1 year for children or adolescents) of the disturbance, the individ-\",\n",
            "  \"675\": \"ual has never been without the symptoms in Criteria A and B for more than 2 months at a\",\n",
            "  \"676\": \"time.\",\n",
            "  \"677\": \"D. Criteria for a major depressive disorder may be continuously present for 2 years.\",\n",
            "  \"678\": \"E. There has never been a manic episode or a hypomanic episode, and criteria have\",\n",
            "  \"679\": \"never been met for cyclothymic disorder.\",\n",
            "  \"680\": \"F. The disturbance is not better explained by a persistent schizoaffective disorder,\",\n",
            "  \"681\": \"schizophrenia, delusional disorder, or other specified or unspecified schizophrenia\",\n",
            "  \"682\": \"spectrum and other psychotic disorder.\",\n",
            "  \"683\": \"G. The symptoms are not attributable to the physiological effects of a substance (e.g., a\",\n",
            "  \"684\": \"drug of abuse, a medication) or another medical condition (e.g. hypothyroidism).\",\n",
            "  \"685\": \"H. The symptoms cause clinically significant distress or impairment in social, occupational,\",\n",
            "  \"686\": \"or other important areas of functioning.\",\n",
            "  \"687\": \"Note: Because the criteria for a major depressive episode include four symptoms that are\",\n",
            "  \"688\": \"absent from the symptom list for persistent depressive disorder (dysthymia), a very limited\",\n",
            "  \"689\": \"Persistent Depressive Disorder (Dysthymia) 169\",\n",
            "  \"690\": \"number of individuals will have depressive symptoms that have persisted longer than 2 years\",\n",
            "  \"691\": \"but will not meet criteria for persistent depressive disorder. If full criteria for a major de-\",\n",
            "  \"692\": \"pressive episode have been met at some point during the current episode of illness, they\",\n",
            "  \"693\": \"should be given a diagnosis of major depressive disorder. Otherwise, a diagnosis of other\",\n",
            "  \"694\": \"specified depressive disorder or unspecified depressive disorder is warranted.\",\n",
            "  \"695\": \"Specify if:\",\n",
            "  \"696\": \"With anxious distress (p. 184)\",\n",
            "  \"697\": \"With mixed features (pp. 184\\u2013185)\",\n",
            "  \"698\": \"With melancholic features (p. 185)\",\n",
            "  \"699\": \"With atypical features (pp. 185\\u2013186)\",\n",
            "  \"700\": \"With mood-congruent psychotic features (p. 186)\",\n",
            "  \"701\": \"With mood-incongruent psychotic features (p. 186)\",\n",
            "  \"702\": \"With peripartum onset (pp. 186\\u2013187)\",\n",
            "  \"703\": \"Specify if:\",\n",
            "  \"704\": \"In partial remission (p. 188)\",\n",
            "  \"705\": \"In full remission (p. 188)\",\n",
            "  \"706\": \"Specify if:\",\n",
            "  \"707\": \"Early onset: If onset is before age 21 years.\",\n",
            "  \"708\": \"Late onset: If onset is at age 21 years or older.\",\n",
            "  \"709\": \"Specify if (for most recent 2 years of persistent depressive disorder):\",\n",
            "  \"710\": \"With pure dysthymic syndrome: Full criteria for a major depressive episode have not\",\n",
            "  \"711\": \"been met in at least the preceding 2 years.\",\n",
            "  \"712\": \"With persistent major depressive episode: Full criteria for a major depressive epi-\",\n",
            "  \"713\": \"sode have been met throughout the preceding 2-year period.\",\n",
            "  \"714\": \"With intermittent major depressive episodes, with current episode: Full criteria for\",\n",
            "  \"715\": \"a major depressive episode are currently met, but there have been periods of at least\",\n",
            "  \"1.716\": \"weeks in at least the preceding 2 years with symptoms below the threshold for a full\",\n",
            "  \"717\": \"major depressive episode.\",\n",
            "  \"718\": \"With intermittent major depressive episodes, without current episode: Full crite-\",\n",
            "  \"719\": \"ria for a major depressive episode are not currently met, but there has been one or\",\n",
            "  \"720\": \"more major depressive episodes in at least the preceding 2 years.\",\n",
            "  \"721\": \"Specify current severity:\",\n",
            "  \"722\": \"Mild (p. 188)\",\n",
            "  \"723\": \"Moderate (p. 188)\",\n",
            "  \"724\": \"Severe (p. 188)\",\n",
            "  \"725\": \"Diagnostic Features\",\n",
            "  \"726\": \"The essential feature of persistent depressive disorder (dysthymia) is a depressed mood\",\n",
            "  \"727\": \"that occurs for most of the day, for more days than not, for at least 2 years, or at least 1 year\",\n",
            "  \"728\": \"for children and adolescents (Criterion A). This disorder represents a consolidation of\",\n",
            "  \"729\": \"DSM-IV-defined chronic major depressive disorder and dysthymic disorder. Major de-\",\n",
            "  \"730\": \"pression may precede persistent depressive disorder, and major depressive episodes may\",\n",
            "  \"731\": \"occur during persistent depressive disorder. Individuals whose symptoms meet major de-\",\n",
            "  \"732\": \"pressive disorder criteria for 2 years should be given a diagnosis of persistent depressive\",\n",
            "  \"733\": \"disorder as well as major depressive disorder.\",\n",
            "  \"734\": \"Individuals with persistent depressive disorder describe their mood as sad or \\u201cdown\",\n",
            "  \"735\": \"in the dumps.\\u201d During periods of depressed mood, at least two of the six symptoms from\",\n",
            "  \"736\": \"Criterion B are present. Because these symptoms have become a part of the individual\\u2019s\",\n",
            "  \"737\": \"day-to-day experience, particularly in the case of early onset (e.g., \\u201cI\\u2019ve always been this\",\n",
            "  \"1.738\": \"Depressive Disorders\",\n",
            "  \"739\": \"way\\u201d), they may not be reported unless the individual is directly prompted. During the 2-year\",\n",
            "  \"740\": \"period (1 year for children or adolescents), any symptom-free intervals last no longer than\",\n",
            "  \"1.741\": \"months (Criterion C).\",\n",
            "  \"742\": \"Prevalence\",\n",
            "  \"743\": \"Persistent depressive disorder is effectively an amalgam of DSM-IV dysthymic disorder and\",\n",
            "  \"744\": \"chronic major depressive episode. The 12-month prevalence in the United States is approxi-\",\n",
            "  \"745\": \"mately 0.5% for persistent depressive disorder and 1.5% for chronic major depressive disorder.\",\n",
            "  \"746\": \"Development and Course\",\n",
            "  \"747\": \"Persistent depressive disorder often has an early and insidious onset (i.e., in childhood,\",\n",
            "  \"748\": \"adolescence, or early adult life) and, by definition, a chronic course. Among individuals\",\n",
            "  \"749\": \"with both persistent depressive disorder and borderline personality disorder, the covari-\",\n",
            "  \"750\": \"ance of the corresponding features over time suggests the operation of a common mecha-\",\n",
            "  \"751\": \"nism. Early onset (i.e., before age 21 years) is associated with a higher likelihood of\",\n",
            "  \"752\": \"comorbid personality disorders and substance use disorders.\",\n",
            "  \"753\": \"When symptoms rise to the level of a major depressive episode, they are likely to sub-\",\n",
            "  \"754\": \"sequently revert to a lower level. However, depressive symptoms are much less likely to\",\n",
            "  \"755\": \"resolve in a given period of time in the context of persistent depressive disorder than they\",\n",
            "  \"756\": \"are in a major depressive episode.\",\n",
            "  \"757\": \"Risk and Prognostic Factors\",\n",
            "  \"758\": \"Temperamental. Factors predictive of poorer long-term outcome include higher levels\",\n",
            "  \"759\": \"of neuroticism (negative affectivity), greater symptom severity, poorer global functioning,\",\n",
            "  \"760\": \"and presence of anxiety disorders or conduct disorder.\",\n",
            "  \"761\": \"Environmental. Childhood risk factors include parental loss or separation.\",\n",
            "  \"762\": \"Genetic and physiological. There are no clear differences in illness development, course,\",\n",
            "  \"763\": \"or family history between DSM-IV dysthymic disorder and chronic major depressive dis-\",\n",
            "  \"764\": \"order. Earlier findings pertaining to either disorder are therefore likely to apply to per-\",\n",
            "  \"765\": \"sistent depressive disorder. It is thus likely that individuals with persistent depressive\",\n",
            "  \"766\": \"disorder will have a higher proportion of first-degree relatives with persistent depressive\",\n",
            "  \"767\": \"disorder than do individuals with major depressive disorder, and more depressive disor-\",\n",
            "  \"768\": \"ders in general.\",\n",
            "  \"3.769\": \"number of brain regions (e.g., prefrontal cortex, anterior cingulate, amygdala, hip-\",\n",
            "  \"770\": \"pocampus) have been implicated in persistent depressive disorder. Possible polysomno-\",\n",
            "  \"771\": \"graphic abnormalities exist as well.\",\n",
            "  \"772\": \"Functional Consequences of\",\n",
            "  \"773\": \"Persistent Depressive Disorder\",\n",
            "  \"774\": \"The degree to which persistent depressive disorder impacts social and occupational func-\",\n",
            "  \"775\": \"tioning is likely to vary widely, but effects can be as great as or greater than those of major\",\n",
            "  \"776\": \"depressive disorder.\",\n",
            "  \"777\": \"Differential Diagnosis\",\n",
            "  \"778\": \"Major depressive disorder. If there is a depressed mood plus two or more symptoms\",\n",
            "  \"779\": \"meeting criteria for a persistent depressive episode for 2 years or more, then the diagnosis of\",\n",
            "  \"780\": \"persistent depressive disorder is made. The diagnosis depends on the 2-year duration,\",\n",
            "  \"781\": \"which distinguishes it from episodes of depression that do not last 2 years. If the symptom\",\n",
            "  \"782\": \"Premenstrual Dysphoric Disorder 171\",\n",
            "  \"783\": \"criteria are sufficient for a diagnosis of a major depressive episode at any time during this pe-\",\n",
            "  \"784\": \"riod, then the diagnosis of major depression should be noted, but it is coded not as a separate\",\n",
            "  \"785\": \"diagnosis but rather as a specifier with the diagnosis of persistent depressive disorder. If the\",\n",
            "  \"786\": \"individual\\u2019s symptoms currently meet full criteria for a major depressive episode, then the\",\n",
            "  \"787\": \"specifier of \\u201cwith intermittent major depressive episodes, with current episode\\u201d would be\",\n",
            "  \"788\": \"made. If the major depressive episode has persisted for at least a 2-year duration and re-\",\n",
            "  \"789\": \"mains present, then the specifier \\u201cwith persistent major depressive episode\\u201d is used. When\",\n",
            "  \"790\": \"full major depressive episode criteria are not currently met but there has been at least one\",\n",
            "  \"791\": \"previous episode of major depression in the context of at least 2 years of persistent depres-\",\n",
            "  \"792\": \"sive symptoms, then the specifier of \\u201cwith intermittent major depressive episodes, without\",\n",
            "  \"793\": \"current episode\\u201d is used. If the individual has not experienced an episode of major depres-\",\n",
            "  \"794\": \"sion in the last 2 years, then the specifier \\u201cwith pure dysthymic syndrome\\u201d is used.\",\n",
            "  \"795\": \"Psychotic disorders. Depressive symptoms are a common associated feature of chronic\",\n",
            "  \"796\": \"psychotic disorders (e.g., schizoaffective disorder, schizophrenia, delusional disorder). A\",\n",
            "  \"797\": \"separate diagnosis of persistent depressive disorder is not made if the symptoms occur\",\n",
            "  \"798\": \"only during the course of the psychotic disorder (including residual phases).\",\n",
            "  \"799\": \"Depressive or bipolar and related disorder due to another medical condition. Persistent\",\n",
            "  \"800\": \"depressive disorder must be distinguished from a depressive or bipolar and related dis-\",\n",
            "  \"801\": \"order due to another medical condition. The diagnosis is depressive or bipolar and related\",\n",
            "  \"802\": \"disorder due to another medical condition if the mood disturbance is judged, based on his-\",\n",
            "  \"803\": \"tory, physical examination, or laboratory findings, to be attributable to the direct patho-\",\n",
            "  \"804\": \"physiological effects of a specific, usually chronic, medical condition (e.g., multiple\",\n",
            "  \"805\": \"sclerosis). If it is judged that the depressive symptoms are not attributable to the physiolog-\",\n",
            "  \"806\": \"ical effects of another medical condition, then the primary mental disorder (e.g., persistent\",\n",
            "  \"807\": \"depressive disorder) is recorded, and the medical condition is noted as a concomitant med-\",\n",
            "  \"808\": \"ical condition (e.g., diabetes mellitus).\",\n",
            "  \"809\": \"Substance/medication-induced depressive or bipolar disorder. A substance/medi-\",\n",
            "  \"810\": \"cation-induced depressive or bipolar and related disorder is distinguished from persis-\",\n",
            "  \"811\": \"tent depressive disorder when a substance (e.g., a drug of abuse, a medication, a toxin) is\",\n",
            "  \"812\": \"judged to be etiologically related to the mood disturbance.\",\n",
            "  \"813\": \"Personality disorders. Often, there is evidence of a coexisting personality disturbance.\",\n",
            "  \"814\": \"When an individual\\u2019s presentation meets the criteria for both persistent depressive disor-\",\n",
            "  \"815\": \"der and a personality disorder, both diagnoses are given.\",\n",
            "  \"816\": \"Comorbidity\",\n",
            "  \"817\": \"In comparison to individuals with major depressive disorder, those with persistent de-\",\n",
            "  \"818\": \"pressive disorder are at higher risk for psychiatric comorbidity in general, and for anxiety\",\n",
            "  \"819\": \"disorders and substance use disorders in particular. Early-onset persistent depressive dis-\",\n",
            "  \"820\": \"order is strongly associated with DSM-IV Cluster B and C personality disorders.\",\n",
            "  \"821\": \"Premenstrual Dysphoric Disorder\",\n",
            "  \"822\": \"Diagnostic Criteria 625.4 (N94.3)\",\n",
            "  \"823\": \"A. In the majority of menstrual cycles, at least five symptoms must be present in the final\",\n",
            "  \"824\": \"week before the onset of menses, start to improve within a few days after the onset of\",\n",
            "  \"825\": \"menses, and become minimal or absent in the week postmenses.\",\n",
            "  \"826\": \"B. One (or more) of the following symptoms must be present:\",\n",
            "  \"827\": \"1. Marked affective lability (e.g., mood swings; feeling suddenly sad or tearful, or in-\",\n",
            "  \"828\": \"creased sensitivity to rejection).\",\n",
            "  \"1.829\": \"Depressive Disorders\",\n",
            "  \"830\": \"2. Marked irritability or anger or increased interpersonal conflicts.\",\n",
            "  \"831\": \"3. Marked depressed mood, feelings of hopelessness, or self-deprecating thoughts.\",\n",
            "  \"832\": \"4. Marked anxiety, tension, and/or feelings of being keyed up or on edge.\",\n",
            "  \"833\": \"C. One (or more) of the following symptoms must additionally be present, to reach a total\",\n",
            "  \"834\": \"of five symptoms when combined with symptoms from Criterion B above.\",\n",
            "  \"835\": \"1. Decreased interest in usual activities (e.g., work, school, friends, hobbies).\",\n",
            "  \"836\": \"2. Subjective difficulty in concentration.\",\n",
            "  \"837\": \"3. Lethargy, easy fatigability, or marked lack of energy.\",\n",
            "  \"838\": \"4. Marked change in appetite; overeating; or specific food cravings.\",\n",
            "  \"839\": \"5. Hypersomnia or insomnia.\",\n",
            "  \"840\": \"6. A sense of being overwhelmed or out of control.\",\n",
            "  \"841\": \"7. Physical symptoms such as breast tenderness or swelling, joint or muscle pain, a\",\n",
            "  \"842\": \"sensation of \\u201cbloating,\\u201d or weight gain.\",\n",
            "  \"843\": \"Note: The symptoms in Criteria A\\u2013C must have been met for most menstrual cycles that\",\n",
            "  \"844\": \"occurred in the preceding year.\",\n",
            "  \"845\": \"D. The symptoms are associated with clinically significant distress or interference with\",\n",
            "  \"846\": \"work, school, usual social activities, or relationships with others (e.g., avoidance of so-\",\n",
            "  \"847\": \"cial activities; decreased productivity and efficiency at work, school, or home).\",\n",
            "  \"848\": \"E. The disturbance is not merely an exacerbation of the symptoms of another disorder,\",\n",
            "  \"849\": \"such as major depressive disorder, panic disorder, persistent depressive disorder\",\n",
            "  \"850\": \"(dysthymia), or a personality disorder (although it may co-occur with any of these dis-\",\n",
            "  \"851\": \"orders).\",\n",
            "  \"852\": \"F. Criterion A should be confirmed by prospective daily ratings during at least two symptom-\",\n",
            "  \"853\": \"atic cycles. (Note: The diagnosis may be made provisionally prior to this confirmation.)\",\n",
            "  \"854\": \"G. The symptoms are not attributable to the physiological effects of a substance (e.g., a\",\n",
            "  \"855\": \"drug of abuse, a medication, other treatment) or another medical condition (e.g., hy-\",\n",
            "  \"856\": \"perthyroidism).\",\n",
            "  \"857\": \"Recording Procedures\",\n",
            "  \"858\": \"If symptoms have not been confirmed by prospective daily ratings of at least two symp-\",\n",
            "  \"859\": \"tomatic cycles, \\u201cprovisional\\u201d should be noted after the name of the diagnosis (i.e., \\u201cpre-\",\n",
            "  \"860\": \"menstrual dysphoric disorder, provisional\\u201d).\",\n",
            "  \"861\": \"Diagnostic Features\",\n",
            "  \"862\": \"The essential features of premenstrual dysphoric disorder are the expression of mood la-\",\n",
            "  \"863\": \"bility, irritability, dysphoria, and anxiety symptoms that occur repeatedly during the pre-\",\n",
            "  \"864\": \"menstrual phase of the cycle and remit around the onset of menses or shortly thereafter.\",\n",
            "  \"865\": \"These symptoms may be accompanied by behavioral and physical symptoms. Symptoms\",\n",
            "  \"866\": \"must have occurred in most of the menstrual cycles during the past year and must have an\",\n",
            "  \"867\": \"adverse effect on work or social functioning. The intensity and/or expressivity of the ac-\",\n",
            "  \"868\": \"companying symptoms may be closely related to social and cultural background charac-\",\n",
            "  \"869\": \"teristics of the affected female, family perspectives, and more specific factors such as\",\n",
            "  \"870\": \"religious beliefs, social tolerance, and female gender role issues.\",\n",
            "  \"871\": \"Typically, symptoms peak around the time of the onset of menses. Although it is not\",\n",
            "  \"872\": \"uncommon for symptoms to linger into the first few days of menses, the individual must\",\n",
            "  \"873\": \"have a symptom-free period in the follicular phase after the menstrual period begins.\",\n",
            "  \"874\": \"While the core symptoms include mood and anxiety symptoms, behavioral and somatic\",\n",
            "  \"875\": \"symptoms commonly also occur. However, the presence of physical and/or behavioral\",\n",
            "  \"876\": \"symptoms in the absence of mood and/or anxious symptoms is not sufficient for a diag-\",\n",
            "  \"877\": \"Premenstrual Dysphoric Disorder 173\",\n",
            "  \"878\": \"nosis. Symptoms are of comparable severity (but not duration) to those of another mental\",\n",
            "  \"879\": \"disorder, such as a major depressive episode or generalized anxiety disorder. In order to\",\n",
            "  \"880\": \"confirm a provisional diagnosis, daily prospective symptom ratings are required for at\",\n",
            "  \"881\": \"least two symptomatic cycles.\",\n",
            "  \"882\": \"Associated Features Supporting Diagnosis\",\n",
            "  \"883\": \"Delusions and hallucinations have been described in the late luteal phase of the menstrual\",\n",
            "  \"884\": \"cycle but are rare. The premenstrual phase has been considered by some to be a risk period\",\n",
            "  \"885\": \"for suicide.\",\n",
            "  \"886\": \"Prevalence\",\n",
            "  \"887\": \"Twelve-month prevalence of premenstrual dysphoric disorder is between 1.8% and 5.8%\",\n",
            "  \"888\": \"of menstruating women. Estimates are substantially inflated if they are based on retro-\",\n",
            "  \"889\": \"spective reports rather than prospective daily ratings. However, estimated prevalence\",\n",
            "  \"890\": \"based on a daily record of symptoms for 1\\u20132 months may be less representative, as indi-\",\n",
            "  \"891\": \"viduals with the most severe symptoms may be unable to sustain the rating process. The\",\n",
            "  \"892\": \"most rigorous estimate of premenstrual dysphoric disorder is 1.8% for women whose\",\n",
            "  \"893\": \"symptoms meet the full criteria without functional impairment and 1.3% for women\",\n",
            "  \"894\": \"whose symptoms meet the current criteria with functional impairment and without co-oc-\",\n",
            "  \"895\": \"curring symptoms from another mental disorder.\",\n",
            "  \"896\": \"Development and Course\",\n",
            "  \"897\": \"Onset of premenstrual dysphoric disorder can occur at any point after menarche. Inci-\",\n",
            "  \"898\": \"dence of new cases over a 40-month follow-up period is 2.5% (95% confidence interval =\",\n",
            "  \"899\": \"1.7\\u20133.7). Anecdotally, many individuals, as they approach menopause, report that symp-\",\n",
            "  \"900\": \"toms worsen. Symptoms cease after menopause, although cyclical hormone replacement\",\n",
            "  \"901\": \"can trigger the re-expression of symptoms.\",\n",
            "  \"902\": \"Risk and Prognostic Factors\",\n",
            "  \"903\": \"Environmental. Environmental factors associated with the expression of premenstrual\",\n",
            "  \"904\": \"dysphoric disorder include stress, history of interpersonal trauma, seasonal changes, and\",\n",
            "  \"905\": \"sociocultural aspects of female sexual behavior in general, and female gender role in par-\",\n",
            "  \"906\": \"ticular.\",\n",
            "  \"907\": \"Genetic and physiological. Heritability of premenstrual dysphoric disorder is unknown.\",\n",
            "  \"908\": \"However, for premenstrual symptoms, estimates for heritability range between 30% and\",\n",
            "  \"909\": \"80%, with the most stable component of premenstrual symptoms estimated to be about\",\n",
            "  \"910\": \"50% heritable.\",\n",
            "  \"911\": \"Course modifiers. Women who use oral contraceptives may have fewer premenstrual\",\n",
            "  \"912\": \"complaints than do women who do not use oral contraceptives.\",\n",
            "  \"913\": \"Culture-Related Diagnostic Issues\",\n",
            "  \"914\": \"Premenstrual dysphoric disorder is not a culture-bound syndrome and has been observed\",\n",
            "  \"915\": \"in individuals in the United States, Europe, India, and Asia. It is unclear as to whether rates\",\n",
            "  \"916\": \"differ by race. Nevertheless, frequency, intensity, and expressivity of symptoms and help-\",\n",
            "  \"917\": \"seeking patterns may be significantly influenced by cultural factors.\",\n",
            "  \"918\": \"Diagnostic Markers\",\n",
            "  \"919\": \"As indicated earlier, the diagnosis of premenstrual dysphoric disorder is appropriately\",\n",
            "  \"920\": \"confirmed by 2 months of prospective symptom ratings. A number of scales, including the\",\n",
            "  \"1.921\": \"Depressive Disorders\",\n",
            "  \"922\": \"Daily Rating of Severity of Problems and the Visual Analogue Scales for Premenstrual\",\n",
            "  \"923\": \"Mood Symptoms, have undergone validation and are commonly used in clinical trials for\",\n",
            "  \"924\": \"premenstrual dysphoric disorder. The Premenstrual Tension Syndrome Rating Scale has a\",\n",
            "  \"925\": \"self-report and an observer version, both of which have been validated and used widely to\",\n",
            "  \"926\": \"measure illness severity in women who have premenstrual dysphoric disorder.\",\n",
            "  \"927\": \"Functional Consequences of\",\n",
            "  \"928\": \"Premenstrual Dysphoric Disorder\",\n",
            "  \"929\": \"Symptoms must be associated with clinically meaningful distress and/or an obvious and\",\n",
            "  \"930\": \"marked impairment in the ability to function socially or occupationally in the week prior\",\n",
            "  \"931\": \"to menses. Impairment in social functioning may be manifested by marital discord and\",\n",
            "  \"932\": \"problems with children, other family members, or friends. Chronic marital or job prob-\",\n",
            "  \"933\": \"lems should not be confused with dysfunction that occurs only in association with pre-\",\n",
            "  \"934\": \"menstrual dysphoric disorder.\",\n",
            "  \"935\": \"Differential Diagnosis\",\n",
            "  \"936\": \"Premenstrual syndrome. Premenstrual syndrome differs from premenstrual dysphoric\",\n",
            "  \"937\": \"disorder in that a minimum of five symptoms is not required, and there is no stipulation of\",\n",
            "  \"938\": \"affective symptoms for individuals who have premenstrual syndrome. This condition\",\n",
            "  \"939\": \"may be more common than premenstrual dysphoric disorder, although the estimated\",\n",
            "  \"940\": \"prevalence of premenstrual syndrome varies. While premenstrual syndrome shares the\",\n",
            "  \"941\": \"feature of symptom expression during the premenstrual phase of the menstrual cycle, it is\",\n",
            "  \"942\": \"generally considered to be less severe than premenstrual dysphoric disorder. The pres-\",\n",
            "  \"943\": \"ence of physical or behavioral symptoms in the premenstruum, without the required\",\n",
            "  \"944\": \"affective symptoms, likely meets criteria for premenstrual syndrome and not for premen-\",\n",
            "  \"945\": \"strual dysphoric disorder.\",\n",
            "  \"946\": \"Dysmenorrhea. Dysmenorrhea is a syndrome of painful menses, but this is distinct from a\",\n",
            "  \"947\": \"syndrome characterized by affective changes. Moreover, symptoms of dysmenorrhea begin\",\n",
            "  \"948\": \"with the onset of menses, whereas symptoms of premenstrual dysphoric disorder, by defini-\",\n",
            "  \"949\": \"tion, begin before the onset of menses, even if they linger into the first few days of menses.\",\n",
            "  \"950\": \"Bipolar disorder, major depressive disorder, and persistent depressive disorder\",\n",
            "  \"951\": \"(dysthymia). Many women with (either naturally occurring or substance/medication-\",\n",
            "  \"952\": \"induced) bipolar or major depressive disorder or persistent depressive disorder believe\",\n",
            "  \"953\": \"that they have premenstrual dysphoric disorder. However, when they chart symptoms,\",\n",
            "  \"954\": \"they realize that the symptoms do not follow a premenstrual pattern. Women with an-\",\n",
            "  \"955\": \"other mental disorder may experience chronic symptoms or intermittent symptoms that\",\n",
            "  \"956\": \"are unrelated to menstrual cycle phase. However, because the onset of menses constitutes\",\n",
            "  \"957\": \"a memorable event, they may report that symptoms occur only during the premenstruum\",\n",
            "  \"958\": \"or that symptoms worsen premenstrually. This is one of the rationales for the requirement\",\n",
            "  \"959\": \"that symptoms be confirmed by daily prospective ratings. The process of differential di-\",\n",
            "  \"960\": \"agnosis, particularly if the clinician relies on retrospective symptoms only, is made more\",\n",
            "  \"961\": \"difficult because of the overlap between symptoms of premenstrual dysphoric disorder\",\n",
            "  \"962\": \"and some other diagnoses. The overlap of symptoms is particularly salient for differenti-\",\n",
            "  \"963\": \"ating premenstrual dysphoric disorder from major depressive episodes, persistent de-\",\n",
            "  \"964\": \"pressive disorder, bipolar disorders, and borderline personality disorder. However, the\",\n",
            "  \"965\": \"rate of personality disorders is no higher in individuals with premenstrual dysphoric dis-\",\n",
            "  \"966\": \"order than in those without the disorder.\",\n",
            "  \"967\": \"Use of hormonal treatments. Some women who present with moderate to severe pre-\",\n",
            "  \"968\": \"menstrual symptoms may be using hormonal treatments, including hormonal contracep-\",\n",
            "  \"969\": \"tives. If such symptoms occur after initiation of exogenous hormone use, the symptoms\",\n",
            "  \"970\": \"Substance/Medication-Induced Depressive Disorder 175\",\n",
            "  \"971\": \"may be due to the use of hormones rather than to the underlying condition of premen-\",\n",
            "  \"972\": \"strual dysphoric disorder. If the woman stops hormones and the symptoms disappear,\",\n",
            "  \"973\": \"this is consistent with substance/medication-induced depressive disorder.\",\n",
            "  \"974\": \"Comorbidity\",\n",
            "  \"3.975\": \"major depressive episode is the most frequently reported previous disorder in individuals\",\n",
            "  \"976\": \"presenting with premenstrual dysphoric disorder. A wide range of medical (e.g., migraine,\",\n",
            "  \"977\": \"asthma, allergies, seizure disorders) or other mental disorders (e.g., depressive and bipolar\",\n",
            "  \"978\": \"disorders, anxiety disorders, bulimia nervosa, substance use disorders) may worsen in the\",\n",
            "  \"979\": \"premenstrual phase; however, the absence of a symptom-free period during the postmen-\",\n",
            "  \"980\": \"strual interval obviates a diagnosis of premenstrual dysphoric disorder. These conditions\",\n",
            "  \"981\": \"are better considered premenstrual exacerbation of a current mental or medical disorder. Al-\",\n",
            "  \"982\": \"though the diagnosis of premenstrual dysphoric disorder should not be assigned in situa-\",\n",
            "  \"983\": \"tions in which an individual only experiences a premenstrual exacerbation of another\",\n",
            "  \"984\": \"mental or physical disorder, it can be considered in addition to the diagnosis of another men-\",\n",
            "  \"985\": \"tal or physical disorder if the individual experiences symptoms and changes in level of func-\",\n",
            "  \"986\": \"tioning that are characteristic of premenstrual dysphoric disorder and markedly different\",\n",
            "  \"987\": \"from the symptoms experienced as part of the ongoing disorder.\",\n",
            "  \"988\": \"Substance/Medication-Induced\",\n",
            "  \"989\": \"Depressive Disorder\",\n",
            "  \"990\": \"Diagnostic Criteria\",\n",
            "  \"991\": \"A. A prominent and persistent disturbance in mood that predominates in the clinical pic-\",\n",
            "  \"992\": \"ture and is characterized by depressed mood or markedly diminished interest or plea-\",\n",
            "  \"993\": \"sure in all, or almost all, activities.\",\n",
            "  \"994\": \"B. There is evidence from the history, physical examination, or laboratory findings of both\",\n",
            "  \"995\": \"(1) and (2):\",\n",
            "  \"996\": \"1. The symptoms in Criterion A developed during or soon after substance intoxication\",\n",
            "  \"997\": \"or withdrawal or after exposure to a medication.\",\n",
            "  \"998\": \"2. The involved substance/medication is capable of producing the symptoms in Crite-\",\n",
            "  \"999\": \"rion A.\",\n",
            "  \"1000\": \"C. The disturbance is not better explained by a depressive disorder that is not substance/\",\n",
            "  \"1001\": \"medication-induced. Such evidence of an independent depressive disorder could in-\",\n",
            "  \"1002\": \"clude the following:\",\n",
            "  \"1003\": \"The symptoms preceded the onset of the substance/medication use; the symptoms\",\n",
            "  \"1004\": \"persist for a substantial period of time (e.g., about 1 month) after the cessation of acute\",\n",
            "  \"1005\": \"withdrawal or severe intoxication; or there is other evidence suggesting the existence\",\n",
            "  \"1006\": \"of an independent non-substance/medication-induced depressive disorder (e.g., a his-\",\n",
            "  \"1007\": \"tory of recurrent non-substance/medication-related episodes).\",\n",
            "  \"1008\": \"D. The disturbance does not occur exclusively during the course of a delirium.\",\n",
            "  \"1009\": \"E. The disturbance causes clinically significant distress or impairment in social, occupa-\",\n",
            "  \"1010\": \"tional, or other important areas of functioning.\",\n",
            "  \"1011\": \"Note: This diagnosis should be made instead of a diagnosis of substance intoxication or\",\n",
            "  \"1012\": \"substance withdrawal only when the symptoms in Criterion A predominate in the clinical\",\n",
            "  \"1013\": \"picture and when they are sufficiently severe to warrant clinical attention.\",\n",
            "  \"1014\": \"Coding note: The ICD-9-CM and ICD-10-CM codes for the [specific substance/medica-\",\n",
            "  \"1015\": \"tion]-induced depressive disorders are indicated in the table below. Note that the ICD-10-\",\n",
            "  \"1.1016\": \"Depressive Disorders\",\n",
            "  \"1017\": \"CM code depends on whether or not there is a comorbid substance use disorder present for\",\n",
            "  \"1018\": \"the same class of substance. If a mild substance use disorder is comorbid with the substance-\",\n",
            "  \"1019\": \"induced depressive disorder, the 4th position character is \\u201c1,\\u201d and the clinician should record\",\n",
            "  \"1020\": \"\\u201cmild [substance] use disorder\\u201d before the substance-induced depressive disorder (e.g.,\",\n",
            "  \"1021\": \"\\u201cmild cocaine use disorder with cocaine-induced depressive disorder\\u201d). If a moderate or se-\",\n",
            "  \"1022\": \"vere substance use disorder is comorbid with the substance-induced depressive disorder,\",\n",
            "  \"1023\": \"the 4th position character is \\u201c2,\\u201d and the clinician should record \\u201cmoderate [substance] use\",\n",
            "  \"1024\": \"disorder\\u201d or \\u201csevere [substance] use disorder,\\u201d depending on the severity of the comorbid\",\n",
            "  \"1025\": \"substance use disorder. If there is no comorbid substance use disorder (e.g., after a one-\",\n",
            "  \"1026\": \"time heavy use of the substance), then the 4th position character is \\u201c9,\\u201d and the clinician should\",\n",
            "  \"1027\": \"record only the substance-induced depressive disorder.\",\n",
            "  \"1028\": \"ICD-10-CM\",\n",
            "  \"1029\": \"With use\",\n",
            "  \"1030\": \"With use disorder, Without\",\n",
            "  \"1031\": \"disorder, moderate use\",\n",
            "  \"1032\": \"ICD-9-CM mild or severe disorder\",\n",
            "  \"1033\": \"Alcohol 291.89 F10.14 F10.24 F10.94\",\n",
            "  \"1034\": \"Phencyclidine 292.84 F16.14 F16.24 F16.94\",\n",
            "  \"1035\": \"Other hallucinogen 292.84 F16.14 F16.24 F16.94\",\n",
            "  \"1036\": \"Inhalant 292.84 F18.14 F18.24 F18.94\",\n",
            "  \"1037\": \"Opioid 292.84 F11.14 F11.24 F11.94\",\n",
            "  \"1038\": \"Sedative, hypnotic, or anxiolytic 292.84 F13.14 F13.24 F13.94\",\n",
            "  \"1039\": \"Amphetamine (or other 292.84 F15.14 F15.24 F15.94\",\n",
            "  \"1040\": \"stimulant)\",\n",
            "  \"1041\": \"Cocaine 292.84 F14.14 F14.24 F14.94\",\n",
            "  \"1042\": \"Other (or unknown) substance 292.84 F19.14 F19.24 F19.94\",\n",
            "  \"1043\": \"Specify if (see Table1 in the chapter \\u201cSubstance-Related and Addictive Disorders\\u201d for di-\",\n",
            "  \"1044\": \"agnoses associated with substance class):\",\n",
            "  \"1045\": \"With onset during intoxication: If criteria are met for intoxication with the substance\",\n",
            "  \"1046\": \"and the symptoms develop during intoxication.\",\n",
            "  \"1047\": \"With onset during withdrawal: If criteria are met for withdrawal from the substance\",\n",
            "  \"1048\": \"and the symptoms develop during, or shortly after, withdrawal.\",\n",
            "  \"1049\": \"Recording Procedures\",\n",
            "  \"1050\": \"ICD-9-CM. The name of the substance/medication-induced depressive disorder begins\",\n",
            "  \"1051\": \"with the specific substance (e.g., cocaine, dexamethasone) that is presumed to be causing\",\n",
            "  \"1052\": \"the depressive symptoms. The diagnostic code is selected from the table included in the\",\n",
            "  \"1053\": \"criteria set, which is based on the drug class. For substances that do not fit into any of the\",\n",
            "  \"1054\": \"classes (e.g., dexamethasone), the code for \\u201cother substance\\u201d should be used; and in cases\",\n",
            "  \"1055\": \"in which a substance is judged to be an etiological factor but the specific class of substance\",\n",
            "  \"1056\": \"is unknown, the category \\u201cunknown substance\\u201d should be used.\",\n",
            "  \"1057\": \"The name of the disorder is followed by the specification of onset (i.e., onset during in-\",\n",
            "  \"1058\": \"toxication, onset during withdrawal). Unlike the recording procedures for ICD-10-CM,\",\n",
            "  \"1059\": \"which combine the substance-induced disorder and substance use disorder into a single\",\n",
            "  \"1060\": \"Substance/Medication-Induced Depressive Disorder 177\",\n",
            "  \"1061\": \"code, for ICD-9-CM a separate diagnostic code is given for the substance use disorder. For\",\n",
            "  \"1062\": \"example, in the case of depressive symptoms occurring during withdrawal in a man with\",\n",
            "  \"1063\": \"a severe cocaine use disorder, the diagnosis is 292.84 cocaine-induced depressive disorder,\",\n",
            "  \"1064\": \"with onset during withdrawal. An additional diagnosis of 304.20 severe cocaine use dis-\",\n",
            "  \"1065\": \"order is also given. When more than one substance is judged to play a significant role in\",\n",
            "  \"1066\": \"the development of depressive mood symptoms, each should be listed separately (e.g.,\",\n",
            "  \"2.1067\": \"methylphenidate-induced depressive disorder, with onset during withdrawal;\",\n",
            "  \"2.1068\": \"dexamethasone-induced depressive disorder, with onset during intoxication).\",\n",
            "  \"1069\": \"ICD-10-CM. The name of the substance/medication-induced depressive disorder begins\",\n",
            "  \"1070\": \"with the specific substance (e.g., cocaine, dexamethasone) that is presumed to be causing\",\n",
            "  \"1071\": \"the depressive symptoms. The diagnostic code is selected from the table included in the\",\n",
            "  \"1072\": \"criteria set, which is based on the drug class and presence or absence of a comorbid sub-\",\n",
            "  \"1073\": \"stance use disorder. For substances that do not fit into any of the classes (e.g., dexameth-\",\n",
            "  \"1074\": \"asone), the code for \\u201cother substance\\u201d should be used; and in cases in which a substance is\",\n",
            "  \"1075\": \"judged to be an etiological factor but the specific class of substance is unknown, the category\",\n",
            "  \"1076\": \"\\u201cunknown substance\\u201d should be used.\",\n",
            "  \"1077\": \"When recording the name of the disorder, the comorbid substance use disorder (if any) is\",\n",
            "  \"1078\": \"listed first, followed by the word \\u201cwith,\\u201d followed by the name of the substance-induced de-\",\n",
            "  \"1079\": \"pressive disorder, followed by the specification of onset (i.e., onset during intoxication, onset\",\n",
            "  \"1080\": \"during withdrawal). For example, in the case of depressive symptoms occurring during with-\",\n",
            "  \"1081\": \"drawal in a man with a severe cocaine use disorder, the diagnosis is F14.24 severe cocaine use\",\n",
            "  \"1082\": \"disorder with cocaine-induced depressive disorder, with onset during withdrawal. A separate\",\n",
            "  \"1083\": \"diagnosis of the comorbid severe cocaine use disorder is not given. If the substance-induced\",\n",
            "  \"1084\": \"depressive disorder occurs without a comorbid substance use disorder (e.g., after a one-time\",\n",
            "  \"1085\": \"heavy use of the substance), no accompanying substance use disorder is noted (e.g., F16.94\",\n",
            "  \"1086\": \"phencyclidine-induced depressive disorder, with onset during intoxication). When more than\",\n",
            "  \"1087\": \"one substance is judged to play a significant role in the development of depressive mood\",\n",
            "  \"1088\": \"symptoms, each should be listed separately (e.g., F15.24 severe methylphenidate use disorder\",\n",
            "  \"1089\": \"with methylphenidate-induced depressive disorder, with onset during withdrawal; F19.94\",\n",
            "  \"1090\": \"dexamethasone-induced depressive disorder, with onset during intoxication).\",\n",
            "  \"1091\": \"Diagnostic Features\",\n",
            "  \"1092\": \"The diagnostic features of substance/medication-induced depressive disorder include the\",\n",
            "  \"1093\": \"symptoms of a depressive disorder, such as major depressive disorder; however, the de-\",\n",
            "  \"1094\": \"pressive symptoms are associated with the ingestion, injection, or inhalation of a sub-\",\n",
            "  \"1095\": \"stance (e.g., drug of abuse, toxin, psychotropic medication, other medication), and the\",\n",
            "  \"1096\": \"depressive symptoms persist beyond the expected length of physiological effects, intoxi-\",\n",
            "  \"1097\": \"cation, or withdrawal period. As evidenced by clinical history, physical examination, or\",\n",
            "  \"1098\": \"laboratory findings, the relevant depressive disorder should have developed during or\",\n",
            "  \"1099\": \"within 1 month after use of a substance that is capable of producing the depressive disor-\",\n",
            "  \"1100\": \"der (Criterion B1). In addition, the diagnosis is not better explained by an independent\",\n",
            "  \"1101\": \"depressive disorder. Evidence of an independent depressive disorder includes the de-\",\n",
            "  \"1102\": \"pressive disorder preceded the onset of ingestion or withdrawal from the substance; the\",\n",
            "  \"1103\": \"depressive disorder persists beyond a substantial period of time after the cessation of sub-\",\n",
            "  \"1104\": \"stance use; or other evidence suggests the existence of an independent non-substance/\",\n",
            "  \"1105\": \"medication-induced depressive disorder (Criterion C). This diagnosis should not be made\",\n",
            "  \"1106\": \"when symptoms occur exclusively during the course of a delirium (Criterion D). The de-\",\n",
            "  \"1107\": \"pressive disorder associated with the substance use, intoxication, or withdrawal must\",\n",
            "  \"1108\": \"cause clinically significant distress or impairment in social, occupational, or other impor-\",\n",
            "  \"1109\": \"tant areas of functioning to qualify for this diagnosis (Criterion E).\",\n",
            "  \"1110\": \"Some medications (e.g., stimulants, steroids, L-dopa, antibiotics, central nervous\",\n",
            "  \"1111\": \"system drugs, dermatological agents, chemotherapeutic drugs, immunological agents)\",\n",
            "  \"1.1112\": \"Depressive Disorders\",\n",
            "  \"1113\": \"can induce depressive mood disturbances. Clinical judgment is essential to determine\",\n",
            "  \"1114\": \"whether the medication is truly associated with inducing the depressive disorder or\",\n",
            "  \"1115\": \"whether a primary depressive disorder happened to have its onset while the person was\",\n",
            "  \"1116\": \"receiving the treatment. For example, a depressive episode that developed within the first\",\n",
            "  \"1117\": \"several weeks of beginning alpha-methyldopa (an antihypertensive agent) in an individ-\",\n",
            "  \"1118\": \"ual with no history of major depressive disorder would qualify for the diagnosis of med-\",\n",
            "  \"1119\": \"ication-induced depressive disorder. In some cases, a previously established condition\",\n",
            "  \"1120\": \"(e.g., major depressive disorder, recurrent) can recur while the individual is coincidentally\",\n",
            "  \"1121\": \"taking a medication that has the capacity to cause depressive symptoms (e.g., L-dopa, oral\",\n",
            "  \"1122\": \"contraceptives). In such cases, the clinician must make a judgment as to whether the med-\",\n",
            "  \"1123\": \"ication is causative in this particular situation.\",\n",
            "  \"3.1124\": \"substance/medication-induced depressive disorder is distinguished from a primary\",\n",
            "  \"1125\": \"depressive disorder by considering the onset, course, and other factors associated with the\",\n",
            "  \"1126\": \"substance use. There must be evidence from the history, physical examination, or labora-\",\n",
            "  \"1127\": \"tory findings of substance use, abuse, intoxication, or withdrawal prior to the onset of the\",\n",
            "  \"1128\": \"depressive disorder. The withdrawal state for some substances can be relatively pro-\",\n",
            "  \"1129\": \"tracted, and thus intense depressive symptoms can last for a long period after the cessation\",\n",
            "  \"1130\": \"of substance use.\",\n",
            "  \"1131\": \"Prevalence\",\n",
            "  \"1132\": \"In a nationally representative U.S. adult population, the lifetime prevalence of substance/\",\n",
            "  \"1133\": \"medication-induced depressive disorder is 0.26%.\",\n",
            "  \"1134\": \"Development and Course\",\n",
            "  \"3.1135\": \"depressive disorder associated with the use of substance (i.e., alcohol, illicit drugs, or a\",\n",
            "  \"1136\": \"prescribed treatment for a mental disorder or another medical condition) must have its on-\",\n",
            "  \"1137\": \"set while the individual is using the substance or during withdrawal, if there is a with-\",\n",
            "  \"1138\": \"drawal syndrome associated with the substance. Most often, the depressive disorder has\",\n",
            "  \"1139\": \"its onset within the first few weeks or 1 month of use of the substance. Once the substance\",\n",
            "  \"1140\": \"is discontinued, the depressive symptoms usually remit within days to several weeks, de-\",\n",
            "  \"1141\": \"pending on the half-life of the substance/medication and the presence of a withdrawal\",\n",
            "  \"1142\": \"syndrome. If symptoms persist 4 weeks beyond the expected time course of withdrawal of\",\n",
            "  \"1143\": \"a particular substance/medication, other causes for the depressive mood symptoms\",\n",
            "  \"1144\": \"should be considered.\",\n",
            "  \"1145\": \"Although there are a few prospective controlled trials examining the association of de-\",\n",
            "  \"1146\": \"pressive symptoms with use of a medication, most reports are from postmarketing sur-\",\n",
            "  \"1147\": \"veillance studies, retrospective observational studies, or case reports, making evidence of\",\n",
            "  \"1148\": \"causality difficult to determine. Substances implicated in medication-induced depressive\",\n",
            "  \"1149\": \"disorder, with varying degrees of evidence, include antiviral agents (efavirenz), cardio-\",\n",
            "  \"1150\": \"vascular agents (clonidine, guanethidine, methyldopa, reserpine), retinoic acid deriva-\",\n",
            "  \"1151\": \"tives (isotretinoin), antidepressants, anticonvulsants, anti-migraine agents (triptans),\",\n",
            "  \"1152\": \"antipsychotics, hormonal agents (corticosteroids, oral contraceptives, gonadotropin-\",\n",
            "  \"1153\": \"releasing hormone agonists, tamoxifen), smoking cessation agents (varenicline), and im-\",\n",
            "  \"1154\": \"munological agents (interferon). However, other potential substances continue to emerge\",\n",
            "  \"1155\": \"as new compounds are synthesized. A history of such substance use may help increase di-\",\n",
            "  \"1156\": \"agnostic certainty.\",\n",
            "  \"1157\": \"Risk and Prognostic Factors\",\n",
            "  \"1158\": \"Temperamental. Factors that appear to increase the risk of substance/medication-\",\n",
            "  \"1159\": \"induced depressive disorder can be conceptualized as pertaining to the specific type of\",\n",
            "  \"1160\": \"drug or to a group of individuals with underlying alcohol or drug use disorders. Risk fac-\",\n",
            "  \"1161\": \"Substance/Medication-Induced Depressive Disorder 179\",\n",
            "  \"1162\": \"tors common to all drugs include history of major depressive disorder, history of drug-\",\n",
            "  \"1163\": \"induced depression, and psychosocial stressors.\",\n",
            "  \"1164\": \"Environmental. There are also risks factors pertaining to a specific type of medication\",\n",
            "  \"1165\": \"(e.g., increased immune activation prior to treatment for hepatitis C associated with inter-\",\n",
            "  \"1166\": \"feron-alfa-induced depression); high doses (greater than 80 mg/day prednisone-equiva-\",\n",
            "  \"1167\": \"lents) of corticosteroids or high plasma concentrations of efavirenz; and high estrogen/\",\n",
            "  \"1168\": \"progesterone content in oral contraceptives.\",\n",
            "  \"1169\": \"Course modifiers. In a representative U.S. adult population, compared with individuals\",\n",
            "  \"1170\": \"with major depressive disorder who did not have a substance use disorder, individuals\",\n",
            "  \"1171\": \"with substance-induced depressive disorder were more likely to be male, to be black, to\",\n",
            "  \"1172\": \"have at most a high school diploma, to lack insurance, and to have lower family income.\",\n",
            "  \"1173\": \"They were also more likely to report higher family history of substance use disorders and\",\n",
            "  \"1174\": \"antisocial behavior, higher 12-month history of stressful life events, and a greater number\",\n",
            "  \"1175\": \"of DSM-IV major depressive disorder criteria. They were more likely to report feelings of\",\n",
            "  \"1176\": \"worthlessness, insomnia/hypersomnia, and thoughts of death and suicide attempts, but\",\n",
            "  \"1177\": \"less likely to report depressed mood and parental loss by death before age 18 years.\",\n",
            "  \"1178\": \"Diagnostic Markers\",\n",
            "  \"1179\": \"Determination of the substance of use can sometimes be made through laboratory assays\",\n",
            "  \"1180\": \"of the suspected substance in the blood or urine to corroborate the diagnosis.\",\n",
            "  \"1181\": \"Suicide Risk\",\n",
            "  \"1182\": \"Drug-induced or treatment-emergent suicidality represents a marked change in thoughts\",\n",
            "  \"1183\": \"and behavior from the person\\u2019s baseline, is usually temporally associated with initiation of\",\n",
            "  \"1184\": \"a substance, and must be distinguished from the underlying primary mental disorders.\",\n",
            "  \"1185\": \"In regard to the treatment-emergent suicidality associated with antidepressants, a U.S.\",\n",
            "  \"1186\": \"Food and Drug Administration (FDA) advisory committee considered meta-analyses of\",\n",
            "  \"1187\": \"99,839 participants enrolled in 372 randomized clinical trials of antidepressants in trials for\",\n",
            "  \"1188\": \"mental disorders. The analyses showed that when the data were pooled across all adult\",\n",
            "  \"1189\": \"age groups, there was no perceptible increased risk of suicidal behavior or ideation. How-\",\n",
            "  \"1190\": \"ever, in age-stratified analyses, the risk for patients ages 18\\u201324 years was elevated, albeit\",\n",
            "  \"1191\": \"not significantly (odds ratio [OR] = 1.55; 95% confidence interval [CI] = 0.91\\u20132.70). The\",\n",
            "  \"1192\": \"FDA meta-analyses reveal an absolute risk of suicide in patients taking investigational an-\",\n",
            "  \"1193\": \"tidepressants of 0.01%. In conclusion, suicide is clearly an extremely rare treatment-emer-\",\n",
            "  \"1194\": \"gent phenomenon, but the outcome of suicide was serious enough to prompt the FDA to\",\n",
            "  \"1195\": \"issue an expanded black-box warning in 2007 regarding the importance of careful moni-\",\n",
            "  \"1196\": \"toring of treatment-emergent suicidal ideation in patients receiving antidepressants.\",\n",
            "  \"1197\": \"Differential Diagnosis\",\n",
            "  \"1198\": \"Substance intoxication and withdrawal. Depressive symptoms occur commonly in sub-\",\n",
            "  \"1199\": \"stance intoxication and substance withdrawal, and the diagnosis of the substance-specific\",\n",
            "  \"1200\": \"intoxication or withdrawal will usually suffice to categorize the symptom presentation. A\",\n",
            "  \"1201\": \"diagnosis of substance-induced depressive disorder should be made instead of a diag-\",\n",
            "  \"1202\": \"nosis of substance intoxication or substance withdrawal when the mood symptoms are\",\n",
            "  \"1203\": \"sufficiently severe to warrant independent clinical attention. For example, dysphoric\",\n",
            "  \"1204\": \"mood is a characteristic feature of cocaine withdrawal. Substance/medication-induced\",\n",
            "  \"1205\": \"depressive disorder should be diagnosed instead of cocaine withdrawal only if the mood\",\n",
            "  \"1206\": \"disturbance is substantially more intense or longer lasting than what is usually encountered\",\n",
            "  \"1207\": \"with cocaine withdrawal and is sufficiently severe to be a separate focus of attention and\",\n",
            "  \"1208\": \"treatment.\",\n",
            "  \"1.1209\": \"Depressive Disorders\",\n",
            "  \"1210\": \"Primary depressive disorder. A substance/medication-induced depressive disorder is\",\n",
            "  \"1211\": \"distinguished from a primary depressive disorder by the fact that a substance is judged to\",\n",
            "  \"1212\": \"be etiologically related to the symptoms, as described earlier (see section \\u201cDevelopment\",\n",
            "  \"1213\": \"and Course\\u201d for this disorder).\",\n",
            "  \"1214\": \"Depressive disorder due to another medical condition. Because individuals with other\",\n",
            "  \"1215\": \"medical conditions often take medications for those conditions, the clinician must consider the\",\n",
            "  \"1216\": \"possibility that the mood symptoms are caused by the physiological consequences of the med-\",\n",
            "  \"1217\": \"ical condition rather than the medication, in which case depressive disorder due to another\",\n",
            "  \"1218\": \"medical condition is diagnosed. The history often provides the primary basis for such a judg-\",\n",
            "  \"1219\": \"ment. At times, a change in the treatment for the other medical condition (e.g., medication sub-\",\n",
            "  \"1220\": \"stitution or discontinuation) may be needed to determine empirically whether the medication\",\n",
            "  \"1221\": \"is the causative agent. If the clinician has ascertained that the disturbance is a function of both\",\n",
            "  \"1222\": \"another medical condition and substance use or withdrawal, both diagnoses (i.e., depressive\",\n",
            "  \"1223\": \"disorder due to another medical condition and substance/medication-induced depressive\",\n",
            "  \"1224\": \"disorder) may be given. When there is insufficient evidence to determine whether the depres-\",\n",
            "  \"1225\": \"sive symptoms are associated with substance (including a medication) ingestion or with-\",\n",
            "  \"1226\": \"drawal or with another medical condition or are primary (i.e., not a function of either a\",\n",
            "  \"1227\": \"substance or another medical condition), a diagnosis of other specified depressive disorder or\",\n",
            "  \"1228\": \"unspecified depressive disorder would be indicated.\",\n",
            "  \"1229\": \"Comorbidity\",\n",
            "  \"1230\": \"Compared with individuals with major depressive disorder and no comorbid substance\",\n",
            "  \"1231\": \"use disorder, those with substance/medication-induced depressive disorder have higher\",\n",
            "  \"1232\": \"rates of comorbidity with any DSM-IV mental disorder; are more likely to have specific\",\n",
            "  \"1233\": \"DSM-IV disorders of pathological gambling and paranoid, histrionic, and antisocial per-\",\n",
            "  \"1234\": \"sonality disorders; and are less likely to have persistent depressive disorder (dysthymia).\",\n",
            "  \"1235\": \"Compared with individuals with major depressive disorder and a comorbid substance use\",\n",
            "  \"1236\": \"disorder, individuals with substance/medication-induced depressive disorder are more\",\n",
            "  \"1237\": \"likely to have alcohol use disorder, any other substance use disorder, and histrionic per-\",\n",
            "  \"1238\": \"sonality disorder; however, they are less likely to have persistent depressive disorder.\",\n",
            "  \"1239\": \"Depressive Disorder\",\n",
            "  \"1240\": \"Due to Another Medical Condition\",\n",
            "  \"1241\": \"Diagnostic Criteria\",\n",
            "  \"1242\": \"A. A prominent and persistent period of depressed mood or markedly diminished interest\",\n",
            "  \"1243\": \"or pleasure in all, or almost all, activities that predominates in the clinical picture.\",\n",
            "  \"1244\": \"B. There is evidence from the history, physical examination, or laboratory findings that the\",\n",
            "  \"1245\": \"disturbance is the direct pathophysiological consequence of another medical condi-\",\n",
            "  \"1246\": \"tion.\",\n",
            "  \"1247\": \"C. The disturbance is not better explained by another mental disorder (e.g., adjustment\",\n",
            "  \"1248\": \"disorder, with depressed mood, in which the stressor is a serious medical condition).\",\n",
            "  \"1249\": \"D. The disturbance does not occur exclusively during the course of a delirium.\",\n",
            "  \"1250\": \"E. The disturbance causes clinically significant distress or impairment in social, occupa-\",\n",
            "  \"1251\": \"tional, or other important areas of functioning.\",\n",
            "  \"1252\": \"Coding note: The ICD-9-CM code for depressive disorder due to another medical condi-\",\n",
            "  \"1253\": \"tion is 293.83, which is assigned regardless of the specifier. The ICD-10-CM code de-\",\n",
            "  \"1254\": \"pends on the specifier (see below).\",\n",
            "  \"1255\": \"Depressive Disorder Due to Another Medical Condition 181\",\n",
            "  \"1256\": \"Specify if:\",\n",
            "  \"1257\": \"(F06.31) With depressive features: Full criteria are not met for a major depressive\",\n",
            "  \"1258\": \"episode.\",\n",
            "  \"1259\": \"(F06.32) With major depressive\\u2013like episode: Full criteria are met (except Criterion\",\n",
            "  \"1260\": \"C) for a major depressive episode.\",\n",
            "  \"1261\": \"(F06.34) With mixed features: Symptoms of mania or hypomania are also present but\",\n",
            "  \"1262\": \"do not predominate in the clinical picture.\",\n",
            "  \"1263\": \"Coding note: Include the name of the other medical condition in the name of the mental dis-\",\n",
            "  \"1264\": \"order (e.g., 293.83 [F06.31] depressive disorder due to hypothyroidism, with depressive fea-\",\n",
            "  \"1265\": \"tures). The other medical condition should also be coded and listed separately immediately\",\n",
            "  \"1266\": \"before the depressive disorder due to the medical condition (e.g., 244.9 [E03.9] hypothyroid-\",\n",
            "  \"1267\": \"ism; 293.83 [F06.31] depressive disorder due to hypothyroidism, with depressive features).\",\n",
            "  \"1268\": \"Diagnostic Features\",\n",
            "  \"1269\": \"The essential feature of depressive disorder due to another medical condition is a promi-\",\n",
            "  \"1270\": \"nent and persistent period of depressed mood or markedly diminished interest or plea-\",\n",
            "  \"1271\": \"sure in all, or almost all, activities that predominates in the clinical picture (Criterion A)\",\n",
            "  \"1272\": \"and that is thought to be related to the direct physiological effects of another medical con-\",\n",
            "  \"1273\": \"dition (Criterion B). In determining whether the mood disturbance is due to a general\",\n",
            "  \"1274\": \"medical condition, the clinician must first establish the presence of a general medical con-\",\n",
            "  \"1275\": \"dition. Further, the clinician must establish that the mood disturbance is etiologically re-\",\n",
            "  \"1276\": \"lated to the general medical condition through a physiological mechanism. A careful and\",\n",
            "  \"1277\": \"comprehensive assessment of multiple factors is necessary to make this judgment. Al-\",\n",
            "  \"1278\": \"though there are no infallible guidelines for determining whether the relationship\",\n",
            "  \"1279\": \"between the mood disturbance and the general medical condition is etiological, several\",\n",
            "  \"1280\": \"considerations provide some guidance in this area. One consideration is the presence of a\",\n",
            "  \"1281\": \"temporal association between the onset, exacerbation, or remission of the general medical\",\n",
            "  \"1282\": \"condition and that of the mood disturbance. A second consideration is the presence of fea-\",\n",
            "  \"1283\": \"tures that are atypical of primary Mood Disorders (e.g., atypical age at onset or course or\",\n",
            "  \"1284\": \"absence of family history). Evidence from the literature that suggests that there can be a di-\",\n",
            "  \"1285\": \"rect association between the general medical condition in question and the development\",\n",
            "  \"1286\": \"of mood symptoms can provide a useful context in the assessment of a particular situation.\",\n",
            "  \"1287\": \"Associated Features Supporting Diagnosis\",\n",
            "  \"1288\": \"Etiology (i.e., a causal relationship to another medical condition based on best clinical ev-\",\n",
            "  \"1289\": \"idence) is the key variable in depressive disorder due to another medical condition. The\",\n",
            "  \"1290\": \"listing of the medical conditions that are said to be able to induce major depression is never\",\n",
            "  \"1291\": \"complete, and the clinician\\u2019s best judgment is the essence of this diagnosis.\",\n",
            "  \"1292\": \"There are clear associations, as well as some neuroanatomical correlates, of depression\",\n",
            "  \"1293\": \"with stroke, Huntington\\u2019s disease, Parkinson\\u2019s disease, and traumatic brain injury. Among\",\n",
            "  \"1294\": \"the neuroendocrine conditions most closely associated with depression are Cushing\\u2019s dis-\",\n",
            "  \"1295\": \"ease and hypothyroidism. There are numerous other conditions thought to be associated\",\n",
            "  \"1296\": \"with depression, such as multiple sclerosis. However, the literature\\u2019s support for a causal\",\n",
            "  \"1297\": \"association is greater with some conditions, such as Parkinson\\u2019s disease and Huntington\\u2019s\",\n",
            "  \"1298\": \"disease, than with others, for which the differential diagnosis may be adjustment disorder,\",\n",
            "  \"1299\": \"with depressed mood.\",\n",
            "  \"1300\": \"Development and Course\",\n",
            "  \"1301\": \"Following stroke, the onset of depression appears to be very acute, occurring within 1 day\",\n",
            "  \"1302\": \"or a few days of the cerebrovascular accident (CVA) in the largest case series. However, in\",\n",
            "  \"1.1303\": \"Depressive Disorders\",\n",
            "  \"1304\": \"some cases, onset of the depression is weeks to months following the CVA. In the largest\",\n",
            "  \"1305\": \"series, the duration of the major depressive episode following stroke was 9\\u201311 months on\",\n",
            "  \"1306\": \"average. Similarly, in Huntington\\u2019s disease the depressive state comes quite early in the\",\n",
            "  \"1307\": \"course of the illness. With Parkinson\\u2019s disease and Huntington\\u2019s disease, it often precedes\",\n",
            "  \"1308\": \"the major motor impairments and cognitive impairments associated with each condition.\",\n",
            "  \"1309\": \"This is more prominently the case for Huntington\\u2019s disease, in which depression is con-\",\n",
            "  \"1310\": \"sidered to be the first neuropsychiatric symptom. There is some observational evidence\",\n",
            "  \"1311\": \"that depression is less common as the dementia of Huntington\\u2019s disease progresses.\",\n",
            "  \"1312\": \"Risk and Prognostic Factors\",\n",
            "  \"1313\": \"The risk of acute onset of a major depressive disorder following a CVA (within 1 day to a\",\n",
            "  \"1314\": \"week of the event) appears to be strongly correlated with lesion location, with greatest risk\",\n",
            "  \"1315\": \"associated with left frontal strokes and least risk apparently associated with right frontal\",\n",
            "  \"1316\": \"lesions in those individuals who present within days of the stroke. The association with\",\n",
            "  \"1317\": \"frontal regions and laterality is not observed in depressive states that occur in the 2\\u20136 months\",\n",
            "  \"1318\": \"following stroke.\",\n",
            "  \"1319\": \"Gender-Related Diagnostic Issues\",\n",
            "  \"1320\": \"Gender differences pertain to those associated with the medical condition (e.g., systemic\",\n",
            "  \"1321\": \"lupus erythematosus is more common in females; stroke is somewhat more common in\",\n",
            "  \"1322\": \"middle-age males compared with females).\",\n",
            "  \"1323\": \"Diagnostic Markers\",\n",
            "  \"1324\": \"Diagnostic markers pertain to those associated with the medical condition (e.g., steroid\",\n",
            "  \"1325\": \"levels in blood or urine to help corroborate the diagnosis of Cushing\\u2019s disease, which can\",\n",
            "  \"1326\": \"be associated with manic or depressive syndromes).\",\n",
            "  \"1327\": \"Suicide Risk\",\n",
            "  \"1328\": \"There are no epidemiological studies that provide evidence to differentiate the risk of sui-\",\n",
            "  \"1329\": \"cide from a major depressive episode due to another medical condition compared with the\",\n",
            "  \"1330\": \"risk from a major depressive episode in general. There are case reports of suicides in\",\n",
            "  \"1331\": \"association with major depressive episodes associated with another medical condition.\",\n",
            "  \"1332\": \"There is a clear association between serious medical illnesses and suicide, particularly\",\n",
            "  \"1333\": \"shortly after onset or diagnosis of the illness. Thus, it would be prudent to assume that the\",\n",
            "  \"1334\": \"risk of suicide for major depressive episodes associated with medical conditions is not less\",\n",
            "  \"1335\": \"than that for other forms of major depressive episode, and might even be greater.\",\n",
            "  \"1336\": \"Functional Consequences of Depressive Disorder\",\n",
            "  \"1337\": \"Due to Another Medical Condition\",\n",
            "  \"1338\": \"Functional consequences pertain to those associated with the medical condition. In gen-\",\n",
            "  \"1339\": \"eral, it is believed, but not established, that a major depressive episode induced by Cush-\",\n",
            "  \"1340\": \"ing\\u2019s disease will not recur if the Cushing\\u2019s disease is cured or arrested. However, it is also\",\n",
            "  \"1341\": \"suggested, but not established, that mood syndromes, including depressive and manic/\",\n",
            "  \"1342\": \"hypomanic ones, may be episodic (i.e., recurring) in some individuals with static brain in-\",\n",
            "  \"1343\": \"juries and other central nervous system diseases.\",\n",
            "  \"1344\": \"Differential Diagnosis\",\n",
            "  \"1345\": \"Depressive disorders not due to another medical condition. Determination of whether\",\n",
            "  \"1346\": \"a medical condition accompanying a depressive disorder is causing the disorder depends\",\n",
            "  \"1347\": \"on a) the absence of an episode(s) of depressive episodes prior to the onset of the medical\",\n",
            "  \"1348\": \"Other Specified Depressive Disorder 183\",\n",
            "  \"1349\": \"condition, b) the probability that the associated medical condition has a potential to pro-\",\n",
            "  \"1350\": \"mote or cause a depressive disorder, and c) a course of the depressive symptoms shortly\",\n",
            "  \"1351\": \"after the onset or worsening of the medical condition, especially if the depressive symp-\",\n",
            "  \"1352\": \"toms remit near the time that the medical disorder is effectively treated or remits.\",\n",
            "  \"1353\": \"Medication-induced depressive disorder. An important caveat is that some medical con-\",\n",
            "  \"1354\": \"ditions are treated with medications (e.g., steroids or alpha-interferon) that can induce depres-\",\n",
            "  \"1355\": \"sive or manic symptoms. In these cases, clinical judgment, based on all the evidence in hand, is\",\n",
            "  \"1356\": \"the best way to try to separate the most likely and/or the most important of two etiological fac-\",\n",
            "  \"1357\": \"tors (i.e., association with the medical condition vs. a substance-induced syndrome).\",\n",
            "  \"1358\": \"Adjustment disorders. It is important to differentiate a depressive episode from an ad-\",\n",
            "  \"1359\": \"justment disorder, as the onset of the medical condition is in itself a life stressor that could\",\n",
            "  \"1360\": \"bring on either an adjustment disorder or an episode of major depression. The major dif-\",\n",
            "  \"1361\": \"ferentiating elements are the pervasiveness the depressive picture and the number and\",\n",
            "  \"1362\": \"quality of the depressive symptoms that the patient reports or demonstrates on the mental\",\n",
            "  \"1363\": \"status examination. The differential diagnosis of the associated medical conditions is rel-\",\n",
            "  \"1364\": \"evant but largely beyond the scope of the present manual.\",\n",
            "  \"1365\": \"Comorbidity\",\n",
            "  \"1366\": \"Conditions comorbid with depressive disorder due to another medical condition are those\",\n",
            "  \"1367\": \"associated with the medical conditions of etiological relevance. It has been noted that de-\",\n",
            "  \"1368\": \"lirium can occur before or along with depressive symptoms in individuals with a variety\",\n",
            "  \"1369\": \"of medical conditions, such as Cushing\\u2019s disease. The association of anxiety symptoms,\",\n",
            "  \"1370\": \"usually generalized symptoms, is common in depressive disorders, regardless of cause.\",\n",
            "  \"1371\": \"Other Specified Depressive Disorder\",\n",
            "  \"1.1372\": \"(F32.8)\",\n",
            "  \"1373\": \"This category applies to presentations in which symptoms characteristic of a depressive\",\n",
            "  \"1374\": \"disorder that cause clinically significant distress or impairment in social, occupational, or\",\n",
            "  \"1375\": \"other important areas of functioning predominate but do not meet the full criteria for any of\",\n",
            "  \"1376\": \"the disorders in the depressive disorders diagnostic class. The other specified depressive\",\n",
            "  \"1377\": \"disorder category is used in situations in which the clinician chooses to communicate the\",\n",
            "  \"1378\": \"specific reason that the presentation does not meet the criteria for any specific depressive\",\n",
            "  \"1379\": \"disorder. This is done by recording \\u201cother specified depressive disorder\\u201d followed by the\",\n",
            "  \"1380\": \"specific reason (e.g., \\u201cshort-duration depressive episode\\u201d).\",\n",
            "  \"1381\": \"Examples of presentations that can be specified using the \\u201cother specified\\u201d designation\",\n",
            "  \"1382\": \"include the following:\",\n",
            "  \"1383\": \"1. Recurrent brief depression: Concurrent presence of depressed mood and at least\",\n",
            "  \"1384\": \"four other symptoms of depression for 2\\u201313 days at least once per month (not associ-\",\n",
            "  \"1385\": \"ated with the menstrual cycle) for at least 12 consecutive months in an individual\",\n",
            "  \"1386\": \"whose presentation has never met criteria for any other depressive or bipolar disorder\",\n",
            "  \"1387\": \"and does not currently meet active or residual criteria for any psychotic disorder.\",\n",
            "  \"1388\": \"2. Short-duration depressive episode (4\\u201313 days): Depressed affect and at least four\",\n",
            "  \"1389\": \"of the other eight symptoms of a major depressive episode associated with clinically\",\n",
            "  \"1390\": \"significant distress or impairment that persists for more than 4 days, but less than 14 days,\",\n",
            "  \"1391\": \"in an individual whose presentation has never met criteria for any other depressive or\",\n",
            "  \"1392\": \"bipolar disorder, does not currently meet active or residual criteria for any psychotic dis-\",\n",
            "  \"1393\": \"order, and does not meet criteria for recurrent brief depression.\",\n",
            "  \"1394\": \"3. Depressive episode with insufficient symptoms: Depressed affect and at least one\",\n",
            "  \"1395\": \"of the other eight symptoms of a major depressive episode associated with clinically\",\n",
            "  \"1.1396\": \"Depressive Disorders\",\n",
            "  \"1397\": \"significant distress or impairment that persist for at least 2 weeks in an individual\",\n",
            "  \"1398\": \"whose presentation has never met criteria for any other depressive or bipolar disorder,\",\n",
            "  \"1399\": \"does not currently meet active or residual criteria for any psychotic disorder, and does\",\n",
            "  \"1400\": \"not meet criteria for mixed anxiety and depressive disorder symptoms.\",\n",
            "  \"1401\": \"Unspecified Depressive Disorder\",\n",
            "  \"1.1402\": \"(F32.9)\",\n",
            "  \"1403\": \"This category applies to presentations in which symptoms characteristic of a depressive dis-\",\n",
            "  \"1404\": \"order that cause clinically significant distress or impairment in social, occupational, or other im-\",\n",
            "  \"1405\": \"portant areas of functioning predominate but do not meet the full criteria for any of the disorders\",\n",
            "  \"1406\": \"in the depressive disorders diagnostic class. The unspecified depressive disorder category is\",\n",
            "  \"1407\": \"used in situations in which the clinician chooses not to specify the reason that the criteria are\",\n",
            "  \"1408\": \"not met for a specific depressive disorder, and includes presentations for which there is insuf-\",\n",
            "  \"1409\": \"ficient information to make a more specific diagnosis (e.g., in emergency room settings).\",\n",
            "  \"1410\": \"Specifiers for Depressive Disorders\",\n",
            "  \"1411\": \"Specify if:\",\n",
            "  \"1412\": \"With anxious distress: Anxious distress is defined as the presence of at least two of\",\n",
            "  \"1413\": \"the following symptoms during the majority of days of a major depressive episode or\",\n",
            "  \"1414\": \"persistent depressive disorder (dysthymia):\",\n",
            "  \"1415\": \"1. Feeling keyed up or tense.\",\n",
            "  \"1416\": \"2. Feeling unusually restless.\",\n",
            "  \"1417\": \"3. Difficulty concentrating because of worry.\",\n",
            "  \"1418\": \"4. Fear that something awful may happen.\",\n",
            "  \"1419\": \"5. Feeling that the individual might lose control of himself or herself.\",\n",
            "  \"1420\": \"Specify current severity:\",\n",
            "  \"1421\": \"Mild: Two symptoms.\",\n",
            "  \"1422\": \"Moderate: Three symptoms.\",\n",
            "  \"1423\": \"Moderate-severe: Four or five symptoms.\",\n",
            "  \"1424\": \"Severe: Four or five symptoms and with motor agitation.\",\n",
            "  \"1425\": \"Note: Anxious distress has been noted as a prominent feature of both bipolar and ma-\",\n",
            "  \"1426\": \"jor depressive disorder in both primary care and specialty mental health settings. High\",\n",
            "  \"1427\": \"levels of anxiety have been associated with higher suicide risk, longer duration of ill-\",\n",
            "  \"1428\": \"ness, and greater likelihood of treatment nonresponse. As a result, it is clinically useful\",\n",
            "  \"1429\": \"to specify accurately the presence and severity levels of anxious distress for treatment\",\n",
            "  \"1430\": \"planning and monitoring of response to treatment.\",\n",
            "  \"1431\": \"With mixed features:\",\n",
            "  \"1432\": \"A. At least three of the following manic/hypomanic symptoms are present nearly every\",\n",
            "  \"1433\": \"day during the majority of days of a major depressive episode:\",\n",
            "  \"1434\": \"1. Elevated, expansive mood.\",\n",
            "  \"1435\": \"2. Inflated self-esteem or grandiosity.\",\n",
            "  \"1436\": \"3. More talkative than usual or pressure to keep talking.\",\n",
            "  \"1437\": \"4. Flight of ideas or subjective experience that thoughts are racing.\",\n",
            "  \"1438\": \"5. Increase in energy or goal-directed activity (either socially, at work or school, or\",\n",
            "  \"1439\": \"sexually).\",\n",
            "  \"1440\": \"Specifiers for Depressive Disorders 185\",\n",
            "  \"1441\": \"6. Increased or excessive involvement in activities that have a high potential for\",\n",
            "  \"1442\": \"painful consequences (e.g., engaging in unrestrained buying sprees, sexual in-\",\n",
            "  \"1443\": \"discretions, foolish business investments).\",\n",
            "  \"1444\": \"7. Decreased need for sleep (feeling rested despite sleeping less than usual; to be\",\n",
            "  \"1445\": \"contrasted with insomnia).\",\n",
            "  \"1446\": \"B. Mixed symptoms are observable by others and represent a change from the per-\",\n",
            "  \"1447\": \"son\\u2019s usual behavior.\",\n",
            "  \"1448\": \"C. For individuals whose symptoms meet full criteria for either mania or hypomania,\",\n",
            "  \"1449\": \"the diagnosis should be bipolar I or bipolar II disorder.\",\n",
            "  \"1450\": \"D. The mixed symptoms are not attributable to the physiological effects of a substance\",\n",
            "  \"1451\": \"(e.g., a drug of abuse, a medication or other treatment).\",\n",
            "  \"1452\": \"Note: Mixed features associated with a major depressive episode have been found\",\n",
            "  \"1453\": \"to be a significant risk factor for the development of bipolar I or bipolar II disorder.\",\n",
            "  \"1454\": \"As a result, it is clinically useful to note the presence of this specifier for treatment\",\n",
            "  \"1455\": \"planning and monitoring of response to treatment.\",\n",
            "  \"1456\": \"With melancholic features:\",\n",
            "  \"1457\": \"A. One of the following is present during the most severe period of the current epi-\",\n",
            "  \"1458\": \"sode:\",\n",
            "  \"1459\": \"1. Loss of pleasure in all, or almost all, activities.\",\n",
            "  \"1460\": \"2. Lack of reactivity to usually pleasurable stimuli (does not feel much better, even\",\n",
            "  \"1461\": \"temporarily, when something good happens).\",\n",
            "  \"1462\": \"B. Three (or more) of the following:\",\n",
            "  \"1463\": \"1. A distinct quality of depressed mood characterized by profound despondency,\",\n",
            "  \"1464\": \"despair, and/or moroseness or by so-called empty mood.\",\n",
            "  \"1465\": \"2. Depression that is regularly worse in the morning.\",\n",
            "  \"1466\": \"3. Early-morning awakening (i.e., at least 2 hours before usual awakening).\",\n",
            "  \"1467\": \"4. Marked psychomotor agitation or retardation.\",\n",
            "  \"1468\": \"5. Significant anorexia or weight loss.\",\n",
            "  \"1469\": \"6. Excessive or inappropriate guilt.\",\n",
            "  \"1470\": \"Note: The specifier \\u201cwith melancholic features\\u201d is applied if these features are present\",\n",
            "  \"1471\": \"at the most severe stage of the episode. There is a near-complete absence of the ca-\",\n",
            "  \"1472\": \"pacity for pleasure, not merely a diminution. A guideline for evaluating the lack of reac-\",\n",
            "  \"1473\": \"tivity of mood is that even highly desired events are not associated with marked\",\n",
            "  \"1474\": \"brightening of mood. Either mood does not brighten at all, or it brightens only partially\",\n",
            "  \"1475\": \"(e.g., up to 20%\\u201340% of normal for only minutes at a time). The \\u201cdistinct quality\\u201d of mood\",\n",
            "  \"1476\": \"that is characteristic of the \\u201cwith melancholic features\\u201d specifier is experienced as qual-\",\n",
            "  \"1477\": \"itatively different from that during a nonmelancholic depressive episode. A depressed\",\n",
            "  \"1478\": \"mood that is described as merely more severe, longer lasting, or present without a rea-\",\n",
            "  \"1479\": \"son is not considered distinct in quality. Psychomotor changes are nearly always pres-\",\n",
            "  \"1480\": \"ent and are observable by others.\",\n",
            "  \"1481\": \"Melancholic features exhibit only a modest tendency to repeat across episodes in the\",\n",
            "  \"1482\": \"same individual. They are more frequent in inpatients, as opposed to outpatients; are\",\n",
            "  \"1483\": \"less likely to occur in milder than in more severe major depressive episodes; and are\",\n",
            "  \"1484\": \"more likely to occur in those with psychotic features.\",\n",
            "  \"1485\": \"With atypical features: This specifier can be applied when these features predomi-\",\n",
            "  \"1486\": \"nate during the majority of days of the current or most recent major depressive episode\",\n",
            "  \"1487\": \"or persistent depressive disorder.\",\n",
            "  \"1488\": \"A. Mood reactivity (i.e., mood brightens in response to actual or potential positive\",\n",
            "  \"1489\": \"events).\",\n",
            "  \"1.1490\": \"Depressive Disorders\",\n",
            "  \"1491\": \"B. Two (or more) of the following:\",\n",
            "  \"1492\": \"1. Significant weight gain or increase in appetite.\",\n",
            "  \"1493\": \"2. Hypersomnia.\",\n",
            "  \"1494\": \"3. Leaden paralysis (i.e., heavy, leaden feelings in arms or legs).\",\n",
            "  \"1495\": \"4. A long-standing pattern of interpersonal rejection sensitivity (not limited to epi-\",\n",
            "  \"1496\": \"sodes of mood disturbance) that results in significant social or occupational im-\",\n",
            "  \"1497\": \"pairment.\",\n",
            "  \"1498\": \"C. Criteria are not met for \\u201cwith melancholic features\\u201d or \\u201cwith catatonia\\u201d during the\",\n",
            "  \"1499\": \"same episode.\",\n",
            "  \"1500\": \"Note: \\u201cAtypical depression\\u201d has historical significance (i.e., atypical in contradistinction\",\n",
            "  \"1501\": \"to the more classical agitated, \\u201cendogenous\\u201d presentations of depression that were the\",\n",
            "  \"1502\": \"norm when depression was rarely diagnosed in outpatients and almost never in ado-\",\n",
            "  \"1503\": \"lescents or younger adults) and today does not connote an uncommon or unusual clin-\",\n",
            "  \"1504\": \"ical presentation as the term might imply.\",\n",
            "  \"1505\": \"Mood reactivity is the capacity to be cheered up when presented with positive events\",\n",
            "  \"1506\": \"(e.g., a visit from children, compliments from others). Mood may become euthymic (not\",\n",
            "  \"1507\": \"sad) even for extended periods of time if the external circumstances remain favorable.\",\n",
            "  \"1508\": \"Increased appetite may be manifested by an obvious increase in food intake or by\",\n",
            "  \"1509\": \"weight gain. Hypersomnia may include either an extended period of nighttime sleep or\",\n",
            "  \"1510\": \"daytime napping that totals at least 10 hours of sleep per day (or at least 2 hours more\",\n",
            "  \"1511\": \"than when not depressed). Leaden paralysis is defined as feeling heavy, leaden, or\",\n",
            "  \"1512\": \"weighted down, usually in the arms or legs. This sensation is generally present for at\",\n",
            "  \"1513\": \"least an hour a day but often lasts for many hours at a time. Unlike the other atypical\",\n",
            "  \"1514\": \"features, pathological sensitivity to perceived interpersonal rejection is a trait that has\",\n",
            "  \"1515\": \"an early onset and persists throughout most of adult life. Rejection sensitivity occurs\",\n",
            "  \"1516\": \"both when the person is and is not depressed, though it may be exacerbated during\",\n",
            "  \"1517\": \"depressive periods.\",\n",
            "  \"1518\": \"With psychotic features: Delusions and/or hallucinations are present.\",\n",
            "  \"1519\": \"With mood-congruent psychotic features: The content of all delusions and hal-\",\n",
            "  \"1520\": \"lucinations is consistent with the typical depressive themes of personal inade-\",\n",
            "  \"1521\": \"quacy, guilt, disease, death, nihilism, or deserved punishment.\",\n",
            "  \"1522\": \"With mood-incongruent psychotic features: The content of the delusions or hal-\",\n",
            "  \"1523\": \"lucinations does not involve typical depressive themes of personal inadequacy,\",\n",
            "  \"1524\": \"guilt, disease, death, nihilism, or deserved punishment, or the content is a mixture\",\n",
            "  \"1525\": \"of mood-incongruent and mood-congruent themes.\",\n",
            "  \"1526\": \"With catatonia: The catatonia specifier can apply to an episode of depression if cata-\",\n",
            "  \"1527\": \"tonic features are present during most of the episode. See criteria for catatonia asso-\",\n",
            "  \"1528\": \"ciated with a mental disorder (for a description of catatonia, see the chapter\",\n",
            "  \"1529\": \"\\u201cSchizophrenia Spectrum and Other Psychotic Disorders\\u201d).\",\n",
            "  \"1530\": \"With peripartum onset: This specifier can be applied to the current or, if full criteria\",\n",
            "  \"1531\": \"are not currently met for a major depressive episode, most recent episode of major de-\",\n",
            "  \"1532\": \"pression if onset of mood symptoms occurs during pregnancy or in the 4 weeks follow-\",\n",
            "  \"1533\": \"ing delivery.\",\n",
            "  \"1534\": \"Note: Mood episodes can have their onset either during pregnancy or postpartum.\",\n",
            "  \"1535\": \"Although the estimates differ according to the period of follow-up after delivery, be-\",\n",
            "  \"1536\": \"tween 3% and 6% of women will experience the onset of a major depressive epi-\",\n",
            "  \"1537\": \"sode during pregnancy or in the weeks or months following delivery. Fifty percent\",\n",
            "  \"1538\": \"of \\u201cpostpartum\\u201d major depressive episodes actually begin prior to delivery. Thus,\",\n",
            "  \"1539\": \"these episodes are referred to collectively as peripartum episodes. Women with\",\n",
            "  \"1540\": \"peripartum major depressive episodes often have severe anxiety and even panic\",\n",
            "  \"1541\": \"Specifiers for Depressive Disorders 187\",\n",
            "  \"1542\": \"attacks. Prospective studies have demonstrated that mood and anxiety symptoms\",\n",
            "  \"1543\": \"during pregnancy, as well as the \\u201cbaby blues,\\u201d increase the risk for a postpartum\",\n",
            "  \"1544\": \"major depressive episode.\",\n",
            "  \"1545\": \"Peripartum-onset mood episodes can present either with or without psychotic\",\n",
            "  \"1546\": \"features. Infanticide is most often associated with postpartum psychotic episodes\",\n",
            "  \"1547\": \"that are characterized by command hallucinations to kill the infant or delusions that\",\n",
            "  \"1548\": \"the infant is possessed, but psychotic symptoms can also occur in severe postpar-\",\n",
            "  \"1549\": \"tum mood episodes without such specific delusions or hallucinations.\",\n",
            "  \"1550\": \"Postpartum mood (major depressive or manic) episodes with psychotic features\",\n",
            "  \"1551\": \"appear to occur in from 1 in 500 to 1 in 1,000 deliveries and may be more common\",\n",
            "  \"1552\": \"in primiparous women. The risk of postpartum episodes with psychotic features is\",\n",
            "  \"1553\": \"particularly increased for women with prior postpartum mood episodes but is also\",\n",
            "  \"1554\": \"elevated for those with a prior history of a depressive or bipolar disorder (especially\",\n",
            "  \"1555\": \"bipolar I disorder) and those with a family history of bipolar disorders.\",\n",
            "  \"1556\": \"Once a woman has had a postpartum episode with psychotic features, the risk\",\n",
            "  \"1557\": \"of recurrence with each subsequent delivery is between 30% and 50%. Postpartum\",\n",
            "  \"1558\": \"episodes must be differentiated from delirium occurring in the postpartum period,\",\n",
            "  \"1559\": \"which is distinguished by a fluctuating level of awareness or attention. The postpar-\",\n",
            "  \"1560\": \"tum period is unique with respect to the degree of neuroendocrine alterations and\",\n",
            "  \"1561\": \"psychosocial adjustments, the potential impact of breast-feeding on treatment\",\n",
            "  \"1562\": \"planning, and the long-term implications of a history of postpartum mood disorder\",\n",
            "  \"1563\": \"on subsequent family planning.\",\n",
            "  \"1564\": \"With seasonal pattern: This specifier applies to recurrent major depressive disorder.\",\n",
            "  \"1565\": \"A. There has been a regular temporal relationship between the onset of major depres-\",\n",
            "  \"1566\": \"sive episodes in major depressive disorder and a particular time of the year (e.g.,\",\n",
            "  \"1567\": \"in the fall or winter).\",\n",
            "  \"1568\": \"Note: Do not include cases in which there is an obvious effect of seasonally related\",\n",
            "  \"1569\": \"psychosocial stressors (e.g., regularly being unemployed every winter).\",\n",
            "  \"1570\": \"B. Full remissions (or a change from major depression to mania or hypomania) also\",\n",
            "  \"1571\": \"occur at a characteristic time of the year (e.g., depression disappears in the spring).\",\n",
            "  \"1572\": \"C. In the last 2 years, two major depressive episodes have occurred that demonstrate\",\n",
            "  \"1573\": \"the temporal seasonal relationships defined above and no nonseasonal major de-\",\n",
            "  \"1574\": \"pressive episodes have occurred during that same period.\",\n",
            "  \"1575\": \"D. Seasonal major depressive episodes (as described above) substantially outnum-\",\n",
            "  \"1576\": \"ber the nonseasonal major depressive episodes that may have occurred over the\",\n",
            "  \"1577\": \"individual\\u2019s lifetime.\",\n",
            "  \"1578\": \"Note: The specifier \\u201cwith seasonal pattern\\u201d can be applied to the pattern of major de-\",\n",
            "  \"1579\": \"pressive episodes in major depressive disorder, recurrent. The essential feature is the\",\n",
            "  \"1580\": \"onset and remission of major depressive episodes at characteristic times of the year.\",\n",
            "  \"1581\": \"In most cases, the episodes begin in fall or winter and remit in spring. Less commonly,\",\n",
            "  \"1582\": \"there may be recurrent summer depressive episodes. This pattern of onset and remis-\",\n",
            "  \"1583\": \"sion of episodes must have occurred during at least a 2-year period, without any non-\",\n",
            "  \"1584\": \"seasonal episodes occurring during this period. In addition, the seasonal depressive\",\n",
            "  \"1585\": \"episodes must substantially outnumber any nonseasonal depressive episodes over\",\n",
            "  \"1586\": \"the individual\\u2019s lifetime.\",\n",
            "  \"1587\": \"This specifier does not apply to those situations in which the pattern is better ex-\",\n",
            "  \"1588\": \"plained by seasonally linked psychosocial stressors (e.g., seasonal unemployment or\",\n",
            "  \"1589\": \"school schedule). Major depressive episodes that occur in a seasonal pattern are often\",\n",
            "  \"1590\": \"characterized by prominent energy, hypersomnia, overeating, weight gain, and a crav-\",\n",
            "  \"1591\": \"ing for carbohydrates. It is unclear whether a seasonal pattern is more likely in recur-\",\n",
            "  \"1592\": \"rent major depressive disorder or in bipolar disorders. However, within the bipolar\",\n",
            "  \"1593\": \"disorders group, a seasonal pattern appears to be more likely in bipolar II disorder than\",\n",
            "  \"1.1594\": \"Depressive Disorders\",\n",
            "  \"1595\": \"in bipolar I disorder. In some individuals, the onset of manic or hypomanic episodes\",\n",
            "  \"1596\": \"may also be linked to a particular season.\",\n",
            "  \"1597\": \"The prevalence of winter-type seasonal pattern appears to vary with latitude, age,\",\n",
            "  \"1598\": \"and sex. Prevalence increases with higher latitudes. Age is also a strong predictor of\",\n",
            "  \"1599\": \"seasonality, with younger persons at higher risk for winter depressive episodes.\",\n",
            "  \"1600\": \"Specify if:\",\n",
            "  \"1601\": \"In partial remission: Symptoms of the immediately previous major depressive episode\",\n",
            "  \"1602\": \"are present, but full criteria are not met, or there is a period lasting less than 2 months\",\n",
            "  \"1603\": \"without any significant symptoms of a major depressive episode following the end of\",\n",
            "  \"1604\": \"such an episode.\",\n",
            "  \"1605\": \"In full remission: During the past 2 months, no significant signs or symptoms of the\",\n",
            "  \"1606\": \"disturbance were present.\",\n",
            "  \"1607\": \"Specify current severity:\",\n",
            "  \"1608\": \"Severity is based on the number of criterion symptoms, the severity of those symptoms,\",\n",
            "  \"1609\": \"and the degree of functional disability.\",\n",
            "  \"1610\": \"Mild: Few, if any, symptoms in excess of those required to make the diagnosis are\",\n",
            "  \"1611\": \"present, the intensity of the symptoms is distressing but manageable, and the symp-\",\n",
            "  \"1612\": \"toms result in minor impairment in social or occupational functioning.\",\n",
            "  \"1613\": \"Moderate: The number of symptoms, intensity of symptoms, and/or functional impair-\",\n",
            "  \"1614\": \"ment are between those specified for \\u201cmild\\u201d and \\u201csevere.\\u201d\",\n",
            "  \"1615\": \"Severe: The number of symptoms is substantially in excess of that required to make\",\n",
            "  \"1616\": \"the diagnosis, the intensity of the symptoms is seriously distressing and unmanage-\",\n",
            "  \"1617\": \"able, and the symptoms markedly interfere with social and occupational functioning.\",\n",
            "  \"1618\": \"Anxiety\",\n",
            "  \"1619\": \"Disorders\",\n",
            "  \"1620\": \"Anxiety disorders\",\n",
            "  \"1621\": \"include disorders that share features of excessive fear and anxi-\",\n",
            "  \"1622\": \"ety and related behavioral disturbances. Fear is the emotional response to real or per-\",\n",
            "  \"1623\": \"ceived imminent threat, whereas anxiety is anticipation of future threat. Obviously, these\",\n",
            "  \"1624\": \"two states overlap, but they also differ, with fear more often associated with surges of au-\",\n",
            "  \"1625\": \"tonomic arousal necessary for fight or flight, thoughts of immediate danger, and escape\",\n",
            "  \"1626\": \"behaviors, and anxiety more often associated with muscle tension and vigilance in prep-\",\n",
            "  \"1627\": \"aration for future danger and cautious or avoidant behaviors. Sometimes the level of fear\",\n",
            "  \"1628\": \"or anxiety is reduced by pervasive avoidance behaviors. Panic attacks feature prominently\",\n",
            "  \"1629\": \"within the anxiety disorders as a particular type of fear response. Panic attacks are not lim-\",\n",
            "  \"1630\": \"ited to anxiety disorders but rather can be seen in other mental disorders as well.\",\n",
            "  \"1631\": \"The anxiety disorders differ from one another in the types of objects or situations that\",\n",
            "  \"1632\": \"induce fear, anxiety, or avoidance behavior, and the associated cognitive ideation. Thus,\",\n",
            "  \"1633\": \"while the anxiety disorders tend to be highly comorbid with each other, they can be dif-\",\n",
            "  \"1634\": \"ferentiated by close examination of the types of situations that are feared or avoided and\",\n",
            "  \"1635\": \"the content of the associated thoughts or beliefs.\",\n",
            "  \"1636\": \"Anxiety disorders differ from developmentally normative fear or anxiety by being ex-\",\n",
            "  \"1637\": \"cessive or persisting beyond developmentally appropriate periods. They differ from tran-\",\n",
            "  \"1638\": \"sient fear or anxiety, often stress-induced, by being persistent (e.g., typically lasting 6 months\",\n",
            "  \"1639\": \"or more), although the criterion for duration is intended as a general guide with allowance\",\n",
            "  \"1640\": \"for some degree of flexibility and is sometimes of shorter duration in children (as in sepa-\",\n",
            "  \"1641\": \"ration anxiety disorder and selective mutism). Since individuals with anxiety disorders\",\n",
            "  \"1642\": \"typically overestimate the danger in situations they fear or avoid, the primary determina-\",\n",
            "  \"1643\": \"tion of whether the fear or anxiety is excessive or out of proportion is made by the clinician,\",\n",
            "  \"1644\": \"taking cultural contextual factors into account. Many of the anxiety disorders develop in\",\n",
            "  \"1645\": \"childhood and tend to persist if not treated. Most occur more frequently in females than in\",\n",
            "  \"1646\": \"males (approximately 2:1 ratio). Each anxiety disorder is diagnosed only when the symp-\",\n",
            "  \"1647\": \"toms are not attributable to the physiological effects of a substance/medication or to another\",\n",
            "  \"1648\": \"medical condition or are not better explained by another mental disorder.\",\n",
            "  \"1649\": \"The chapter is arranged developmentally, with disorders sequenced according to the\",\n",
            "  \"1650\": \"typical age at onset. The individual with separation anxiety disorder is fearful or anxious\",\n",
            "  \"1651\": \"about separation from attachment figures to a degree that is developmentally inappro-\",\n",
            "  \"1652\": \"priate. There is persistent fear or anxiety about harm coming to attachment figures and\",\n",
            "  \"1653\": \"events that could lead to loss of or separation from attachment figures and reluctance to go\",\n",
            "  \"1654\": \"away from attachment figures, as well as nightmares and physical symptoms of distress. Al-\",\n",
            "  \"1655\": \"though the symptoms often develop in childhood, they can be expressed throughout adult-\",\n",
            "  \"1656\": \"hood as well.\",\n",
            "  \"1657\": \"Selective mutism is characterized by a consistent failure to speak in social situations in\",\n",
            "  \"1658\": \"which there is an expectation to speak (e.g., school) even though the individual speaks in\",\n",
            "  \"1659\": \"other situations. The failure to speak has significant consequences on achievement in aca-\",\n",
            "  \"1660\": \"demic or occupational settings or otherwise interferes with normal social communication.\",\n",
            "  \"1661\": \"Individuals with specific phobia are fearful or anxious about or avoidant of circum-\",\n",
            "  \"1662\": \"scribed objects or situations. A specific cognitive ideation is not featured in this disorder,\",\n",
            "  \"1663\": \"as it is in other anxiety disorders. The fear, anxiety, or avoidance is almost always imme-\",\n",
            "  \"1664\": \"189\"\n",
            "}\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "WALqOhNGol2L"
      },
      "execution_count": null,
      "outputs": []
    }
  ],
  "metadata": {
    "colab": {
      "provenance": []
    },
    "kernelspec": {
      "display_name": "Python 3",
      "name": "python3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}